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Abstract 
Nephrin is a transmembrane protein belonging to the immunoglobulin superfamily 
and express in the podocytes, which are highly differentiated epithelial cells 
needed for primary urine filtration in the kidney. Mutations leading to nephrin loss 
abrogate podocyte morphology, and result in massive protein loss through urine 
and early death in humans and mice. The purpose of this thesis was to generate 
novel inducible mouse-lines that allow targeted gene deletion in a time and tissue 
specific manner. A gene therapy proof of principle model that allowed podocyte 
specific transgene replacement to rescue gene deficient mice from perinatal 
lethality was studied. Furthermore, the phenotypic consequences of nephrin 
restoration in the kidney and nephrin deficiency in the testis, brain and pancreas 
in rescued mice were investigated.  
A novel podocyte-specific construct was achieved by using standard 
cloning techniques to provide an inducible tool for in vitro and in vivo gene 
targeting. Using modified constructs and standard micro-injection procedures two 
novel transgenic mouse-lines were generated. First, a mouse-line with 
doxycycline inducible expression of Cre recombinase that allows podocyte-
specific gene deletion was generated. Second, a mouse-line with doxycycline 
inducible expression of rat nephrin, which allows podocyte-specific nephrin over-
expression was made. Furthermore, it was possible to rescue nephrin deficient 
mice from perinatal lethality by cross-breeding them with a mouse-line with 
inducible rat nephrin expression that restored the missing endogenous nephrin 
only in the kidney after doxycycline treatment. The rescued mice were smaller, 
infertile, showed genital malformations and developed distinct histological 
abnormalities in the kidney with an altered molecular composition of the 
podocytes. Histological changes were also found in the testis, cerebellum and 
pancreas. The expression of another molecule with limited tissue expression, 
densin, was localized to the plasma membranes of Sertoli cells in the testis by 
immunofluorescence staining. Densin may be an essential adherens junction 
protein between Sertoli cells and developing germ cells and these junctions share 
similar protein assembly with kidney podocytes.  
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This single, binary conditional construct appears to serve as a cost- and 
time-efficient tool to increase the basic understanding of podocyte-specific key 
proteins in health and disease. These results showed a tightly controlled inducible 
podocyte-specific transgene expression in vitro and in vivo as expected. These 
novel mouse-lines with doxycycline inducible Cre recombinase and with rat 
nephrin expression will be useful for conditional deletion of essential podocyte 
proteins and to study in detail their functions after over-expression in adult mice. 
This is important for future diagnostic and pharmacologic development platforms. 
This thesis also proves that inducible podocyte-specific expression of a rat 
nephrin transgene rescues nephrin deficient mice from perinatal death, but in a 
complex fashion that should be considered while designing gene replacement 
therapies. Findings from kidneys of rescued animals indicate that nephrin plays a 
major role in the podocyte, both in the formation of functional filtration slits during 
development and in the formation and maintenance of foot process integrity 
during adulthood, via specific intracellular signaling. Furthermore, the phenotype 
of rescued animals has also revealed the importance of nephrin in male 
reproductive track development. Additional work on the functional role of slit 
diaphragm components in the testis is needed to reveal whether these molecules 
have a direct role in spermatogenesis. 
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Introduction 
The nephron is the functional unit for filtration of the kidney consisting of a 
glomerulus, proximal tubule, Henle’s loop, distal tubule, and collecting duct [1]. 
The glomerulus maintains filtration by forming a three-layered barrier that is 
composed of a layer of endothelial cells, the glomerular basement membrane 
(GBM) and podocytes that form a special extracellular structure called the slit 
diaphragm (SD) [1, 2]. Leaking of proteins into the urine, proteinuria, is often due 
to dysfunction of the SD with functional or structural changes in the corresponding 
molecules.  
Children born with congenital nephrotic syndrome of the Finnish type 
(CNF) suffer from severely impaired podocyte function. Before the development of 
current transplantation therapy these children died within a few months after birth 
due to massive proteinuria [3]. After a meticulous search for the causative gene of  
CNF, the nephrin (NPHS1) gene encoding the slit diaphragm specific protein 
nephrin was identified [4]. Consistent with the human CNF disease phenotype, 
nephrin knock-out (KO) mice die within a few days after birth and the podocytes 
show morphological abnormalities closely similar to those in the glomeruli of CNF 
patients [5, 6].  
In the kidney, nephrin generates junctions between two podocyte cells and 
forms the molecular sieve in the SD [5, 7]. Nephrin also has a role in signal 
transduction and maintenance of the architecture of the podocytes by regulating 
the actin cytoskeleton [8, 9]. However, expression of nephrin is not limited to the 
podocytes, but is also present in the testis [10], the central nervous system (CNS) 
and the pancreas [5, 11]. The most striking kidney manifestation in nephrin KO 
mice is a loss of SD structures and a fusion of podocyte foot processes [5, 6]. 
These mice die as a consequence of massive proteinuria soon after birth and the 
precise glomerular functions of nephrin especially in adulthood remain 
unidentified. Furthermore, whether the absence of nephrin in extra-renal sites in 
nephrin KO mice, also contributes to the lethality is not known and cannot be 
studied with present conventional gene silencing techniques. Importantly, the 
conventional silencing of many other podocyte-specific genes in mice is also 
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associated with early postnatal lethality. Therefore, it is of great importance to 
generate mouse-lines, which allow the study of podocyte-specific gene functions 
in a tissue- and time-specific manner.  
To achieve this goal, a novel tetracycline inducible (Tet-on) podocyte-
specific construct for in vitro and in vivo gene targeting was generated. By 
modifying this construct, two transgenic mouse-lines were developed, (A) an 
inducible podocyte-specific expression of Cre recombinase and (B) a rat nephrin 
protein. These mouse-lines are suitable for conditional gene deletion and further 
characterization of nephrin function in adult mice, respectively. 
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Review of the literature 
1. The kidney: Structure and main functions 
The kidneys are paired organs located retroperitoneally. The kidneys are 
responsible for the ultrafiltration of plasma, excretion of metabolic waste products, 
maintaining water and pH balance and secretion of hormones. Thus, the filtration 
regulates the body fluid balance by affecting the electrolyte contents, osmolarity 
and acidity of body fluids. The nephron is the functional unit for filtration of the 
kidney. Each of the approximately one million nephrons in the human kidney 
consists of a renal corpuscle (glomerulus), proximal tubule, Henle’s loop, distal 
tubule, and collecting duct [1]. 
The glomerulus is responsible for the formation of the primary urine. The 
afferent arteriole, which imports blood to the glomerulus, divides further into five to 
seven smaller capillary branches forming a tight tuft structure of the glomerulus 
surrounded by the urinary space and an epithelial cell-lined Bowman’s capsule. 
The glomerulus maintains filtration by forming a three-layered barrier between the 
blood circulation and the tubular system, which is responsible for the 
reabsorbation of substances like excessive water, smaller proteins and glucose. 
Even though approximately 180 l of primary urine is produced every day, the final 
urine volume is only 1-1.5 l/day [1]. The three-layered glomerular filter filtrates 
primary urine in a size, charge and shape-selective manner [12-15]. Structurally, 
the glomerular filter is composed of a layer of endothelial cells, the glomerular 
basement membrane (GBM) and visceral epithelial cells, called podocytes (Figure 
1A). 
The first layer of the filtration barrier is the endothelial cell layer of the 
capillary lumen wall. The endothelium has large fenestrations and openings up to 
~100 nm, which are spanned by negatively charged glycoproteins and lipids [1]. 
This layer maintains blood cells in circulation, whereas water and many 
macromolecules, e.g. albumin, flow without major restraint through the pores [16, 
17].  
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The second layer, the negatively charged GBM, seems to be the principal 
charge-selective barrier, and probably also the main size-selective barrier [18, 
19]. The GBM forms a size-selective barrier for particles with a size similar to or 
larger than that of albumin, which has a molecular weight of 68 kDa. The GBM is 
composed mainly of Type IV collagen and laminin, but contains also heparan 
sulphate proteoglycans, fibronectin and entactin/nidogen [20, 21]. These 
molecules form a negative charge on the GBM and favour filtration of cationic 
proteins (Figure 1A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The podocyte and the slit diaphragm. A) Transmission electron micrograph of glomeruli. 
Filtrate passes from the glomerular capillary lumen through fenestrated endothelial cells, across 
the glomerular basement membrane (GBM), and through the slit diaphragm (SD) between the 
podocytes into the Bowman’s space. B) Scanning electron micrograph of podocytes. Podocytes 
have long primary processes (P) that extend towards the capillaries to which they attach by foot 
secondary (S) and tertiary (T) processes. In contrast to the cell body (CB), the foot processes 
contain only few organelles. C) A modified slit diaphragm model by Karnowsky et al. 1974. 
Podocyte foot processes (left and right) with a central filament in parallel. Perpendicular cross 
strands form a reticular lattice, with rectangular pores between the strands. 
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1.1. Podocytes and slit diaphragm  
The last layer of the filtration barrier is composed of podocytes, which are 
polarized and highly differentiated epithelial cells. They have a voluminous cell 
body, which bulges into the urinary space. The cell body contains a prominent 
nucleus, a well developed Golgi system, rough and smooth endoplasmic 
reticulum, lysosomes, and many mitochondria [2]. Podocytes have long primary 
processes that extend towards capillaries to which they attach by secondary and 
tertiary foot processes (Figure 1B). In contrast to the cell body, the foot processes 
contain only few organelles. The foot processes between neighbouring podocytes 
regularly interdigitate and a special extracellular structure called the slit 
diaphragm (SD) is formed between them [1, 2].  
The filtration slit has a constant width of ~30-40 nm and is bridged by the 
SD [22-24]. Electron microscopy studies on the structure of the SD reveal a 
zipper-like structure with rod-like units connected to the central filament running 
parallel to the foot processes. This structure forms a molecular sieve with pores of 
the approximate size of an albumin molecule [24, 25]. The SD appears to be a 
crucial structure regulating the glomerular filtration in a size and shape selective 
manner (Figure 1C).  
1.2. Filtration barrier injury leads to proteinuria 
Small and neutral proteins pass the filtration barrier freely and active reabsorbtion 
in the downstream tubular system returns the majority of the proteins back into 
circulation. A filtration barrier injury results in a proteinuric condition, in which 
proteins that are normally kept in the blood circulation leak into the urine. This is 
due to an increased amount of total protein passing through the filtration barrier 
and this subsequently overloads the tubular reabsorption capacity, whereafter 
proteins in the tubular lumen pass freely into the collecting duct and further into 
urine. Leaking of proteins into the urine is due to dysfunction of the glomerular 
filter with functional or structural changes in the corresponding molecules in the 
filter. However, the molecular events that occur in proteinuria are still partly 
unsolved. Glomerular proteinuria is accompanied by podocyte foot processes 
effacement where the foot processes are fused together along the GBM. In 
proteinuric disorders, the effacement can be irreversible leading to progressive 
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proteinuria and in certain cases, development of end-stage renal disease (ESRD). 
The filtration function damage may be reversible with subsequent restoration of 
the foot processes and the SD. There are several known causes of proteinuric 
conditions including autoimmune diseases, local inflammation, toxic effects and 
genetic mutations [2, 19]. Glomerular anomalities and clinical features in some 
familial nephrotic syndromes (NS) caused by genetic mutations are summarized 
in Table 1. 
 
Table 1. Some familial nephrotic syndromes and their clinical features. 
 
Glomerular 
Anomalities 
Mutated 
Protein 
Nephrotic 
Syndrome
Clinical Features Refe-
rences 
I. Changes in 
the SD.  
a. Nephrin 
 
 
 
b. Podocin 
a. CNF 
 
 
 
b. Steroid 
resistant NS 
a. Develop refractory NS within 3 
months of life and progress ESRD 
in 2-3 years of age. 
 
b. Early onset of NS and 
progression to ESRD in childhood. 
[4] 
 
 
 
[26] 
II. Altered 
podocyte 
homeostasis 
due to 
changes in Ca 
influx. 
TRPC 6 Focal and 
segmental 
sclerosis 
(FSGS) 
Onset of proteinuria in adolescence 
and early adulthood. ERSD after 
the fourth decade. 
[27] 
III. Unstable 
cytoskeleton of 
the podocyte 
foot processes. 
Alpha-
actinin-4 
FSGS Onset of proteinuria in adolescence 
and early adulthood. ERSD after 
the fifth decade. 
[28] 
IV. Changes in 
the GBM. 
Laminin  Pierson 
Syndrome 
Early onset of NS soon after birth 
and progression to ESRD in 
childhood. 
[29] 
V. Alterations 
in early 
glomerular 
development. 
a. Wilm’s 
tumour 
protein 
(WT1) 
a. Denys-
Drash 
Syndrome  
 
a. Diffuse mesangial sclerosis or 
FSGS occur in combination with 
Wilms tumor and urogenital 
abnormalities. 
[30] 
 
 
 
2. Congenital nephrotic syndrome of the Finnish type  
CNF is an autosomal recessive renal disease [31-33] and its approximate 
incidence in Finland is 1/10000 live births [34]. Children born with CNF suffer from 
severely impaired podocyte function and, before current transplantation therapy, 
used to die within a few months after birth due to massive proteinuria [3]. The 
understanding of the glomerular filter function has improved, with the finding that 
mutations in NPHS1 gene causes CNF disease [4].  
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At present, more than 70 mutations in NPHS1 gene have been identified 
[35, 36]. In the Finnish population, two main mutations of the NPHS1 gene, 
Finmajor and Finminor have been reported [4]. The most common mutation, Finmajor, 
is a frameshift deletion in exon 2 that forms a stop codon within the same exon 
resulting in complete loss of the nephrin protein [35]. The other Finnish mutation, 
Finminor, is a nonsense mutation in exon 26 that leads to a large deletion of the 
intracellular domain of nephrin [35]. While most prevalent mutations are found in 
Finland, a variety of different mutations leading to various clinical manifestations 
have also been described in other countries [35, 36]. The absence of SD 
structures and nephrin protein expression with clinical manifestations typical to 
CNF disease, has also been reported from patients with either the Finmajor or 
Finminor mutation [37]. 
The clinical features of CNF include massive proteinuria in utero, oedema, 
enlarged placenta and low birth weight [3, 31]. The kidneys of CNF patients are 
bigger compared to healthy controls, and the number and size of glomeruli are 
significantly increased [38, 39]. The number of podocytes is decreased and the 
podocytes show effacement of the foot processes and absence of SDs [40]. Other 
histological findings include dilated proximal tubules, mesangial hypercellularity 
with expansion of the mesangial area, inflammation, thickened GBM and 
thickened parietal epithelial cell layer of Bowman’s capsule [32, 40-43].  
Current treatment of CNF consists of early nephrectomy and dialysis 
followed by transplantation [44]. This treatment removes all symptoms with no 
apparent manifestations in other organs [45]. After transplantation 20% of CNF 
patients develop a recurrence of the nephrotic syndrome, which has been shown 
to result from the presence of nephrin-specific circulating auto-antibodies [46, 47]. 
This recurrence has only been reported in the patients with the Finmajor mutation. 
These patients have an early stop codon in exon 2 of the nephrin gene and lack 
nephrin immunological tolerance [47]. Interestingly, patients with Finminor mutation 
do not show a recurrence of proteinuria after the kidney graft [46, 47]. This may 
be due to immunological tolerance against the partly normal nephrin protein, 
because of a nonsense mutation that occurs relatively late in exon 26.  
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3. Molecular composition of the SD  
During development, the SD originates from the apically located tight junctions of 
the prepodocytes. During formation of the glomerulus, these apical junction 
complexes migrate toward the basal surface and prior to reaching it, nephrin 
appears in the complex [4]. The expression of nephrin is associated with the 
development of foot processes and the emergence of other nephrin-associated 
SD proteins [5]. The molecular composition of the SD is partly similar to tight 
junctions [48, 49] and partly to adherens junctions [49-52]. Therefore the SD can 
be defined as a modified adherens junction. A multitude of podocyte proteins 
relevant to the filtration slit function have recently been characterized. The 
outgrowth of foot processes from the primary process requires polymerization of 
actin microfilaments and their connection to nephrin and other SD proteins [8, 9]. 
The proteins that are crucial for this process remain partly unidentified. Nephrin 
and its associated proteins will be further discussed in this section. 
3.1. Nephrin 
3.1.1. Nephrin gene 
The NPHS1 gene is located on human chromosome 19q13.1. The human gene 
consist of 29 exons and is approximately 26 kb in size [35] and produces a 4.3 kb 
long messenger RNA (mRNA), which is translated into the nephrin protein. 
3.1.2. Structure of nephrin protein 
Human nephrin is a transmembrane protein that consists of 1241 amino acids and 
belongs to the immunoglobulin (Ig) superfamily and cell-cell adhesion molecules 
[4]. Nephrin has different functions in the podocytes. It generates junctions 
between two podocyte cells and forms the molecular sieve in the SD [5, 7]. In 
addition, nephrin also has been suggested to have a role in signal transduction 
and maintenance of the architecture of the podocytes by regulating the actin 
cytoskeleton [8, 9]. Different domains of the nephrin protein are involved in these 
multiple roles (Figure 2A). 
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Figure 2. Nephrin protein structure and phylogenetic protein sequence. A) Nephrin’s extra-cellular 
domain contains eight Ig-like domains and a fibronectin type III-like domain (FN3). After 
transmembrane domain (TM) is an intracellular domain with multiple tyrosine phosphorylation sites 
(Y). In addition, the extracellular domain of nephrin also contains free cysteine residues (C) that 
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may serve as linkers between binding partner(s). B) Phylogenetic comparison of the nephrin 
amino acid sequences of mouse, rat and human. Modified from the original article by Putaala et al. 
2000. Exon borders are marked with a vertical solid red line. Ig motifs are boxed and the 
fibronectin type III-like domain is boxed with a hatched line. The transmembrane domain is 
underlined with a solid line. The signal peptide cleavage site is marked by an arrow (↓).Conserved 
cysteine residues are shaded, unconserved residues are shown in bold, and conserved N-
glycosylation sites are indicated with a triangle ( ). Conserved tyrosine residues in the intracellular 
domain are indicated with a dot (•), and two possible protein kinase C phosphorylation sites with 
the consensus sequence Ser/Tyr-X-Arg/Lys are marked with a star (*).Tyrosine residues shown to 
be important to Nck adaptor protein binding are overlined with a blue solid line. Places for Finmajor 
and Finminor mutations are boxed with a black line. 
 
Like other cell adhesion molecules, nephrin binds itself and related proteins 
by its extracellular domain [53, 54]. The extracellular domain of nephrin consists 
of eight Ig motifs with cysteine residues, which take part in protein-protein 
interactions [4]. All eight Ig motifs in nephrin have two cysteines containing thiol-
groups that form disulfide bonds within the motif, and thus stabilize the folded 
protein structure. The extracellular domain of nephrin also contains free cysteine 
residues that may serve as linkers between binding partner(s) [4].  
Fibronectin type III-like domain encoded by exons 21 and 22, is found 
upstream of the transmembrane domain that is encoded by exon 24. The 
fibronectin domain includes a 90-residue structure with conserved tryptophan and 
tyrosine residues. Its secondary structure resembles an Ig-like fold, thus indicating 
its role in protein-protein interactions [55]. 
The intracellular domain of nephrin is encoded by exons 25-29 resulting in 
a 155-amino acid domain. The presence of nine tyrosine residues, which are 
tentative phosphorylation sites for intracellular signaling, suggest a role for 
nephrin in signal transduction [8, 9, 56-58].  
3.1.3. Phylogenetic comparison of mouse, rat and human nephrin sequence 
The mouse nephrin amino acid sequence shows 93% and 83% identity with the 
rat and the human sequence, respectively (Figure 2B). The most notable 
difference is at the amino terminus, where the mouse and rat proteins are 14 
amino acid residues longer than the human protein. Mouse nephrin has 1256 and 
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rat nephrin has 1252 amino acid residues both predicting a molecular weight of 
136 kD without post-translational modifications [59]. Human nephrin contains 
1241 residues, with a molecular weight of 135 kD [4].  
The signal peptide cleavage site in human nephrin is located between 
residues 22 and 23, whereas it is predicted to be between residues 36 and 37 in 
mouse and rat. All 10 potential N-glycosylation sites are conserved between the 
three species. Glycosylation has been postulated to occur based on the finding of 
a difference between the calculated (135 kDa) and the identified (185 kDa) 
molecular weight of nephrin by Western blot analysis [4]. Of the seven serine-
glycine doublets that are potential heparan sulfate attachment sites, only two are 
conserved between the three species [59].  
All eight Ig motifs contain two cysteines that have been conserved in all 
three species. In addition, the mouse and rat nephrin contain three cysteine 
residues that are conserved between the species, and one or two unconserved 
residues depending on the species. The conserved residues are; one in the first 
Ig- motif, one in the spacer domain, and one in the transmembrane domain. The 
unconserved residues include; one cysteine in Ig motif 4 in the mouse, one each 
in Ig motifs 2 and 4 in the rat, and one residue in the fibronectin III domain in 
human nephrin. Furthermore, both the mouse signal peptide and the rat 
intracellular part have one cysteine residue each [4]. 
The intracellular domain in human nephrin has nine tyrosine residues that 
are tentative phosphorylation sites for intracellular signaling, while the 
corresponding domains of mouse and rat contain ten and eight residues, 
respectively. Six of those tyrosine residues are conserved between the three 
species. However, the sequences around the tyrosines are completely conserved 
between the three species only in the case of three of the residues. In human 
nephrin, these are tyrosines 1113, 1193, and 1217. Recently, the importance of 
three tyrosine residues (1176, 1193, 1217) in the cytoplasmic tail of human 
nephrin has been shown to convey actin polymerization, via the non-catalytic 
region of tyrosine kinase (Nck) adaptor proteins after tyrosine kinase Fyn 
phosphorylation [8, 9, 58]. Furthermore, two potential conserved protein kinase C 
 
 
23
phosphorylation sites with the consensus sequence Ser/Tyr-X-Arg/Lys have also 
been reported [59]. 
3.1.4. Complex fashion of nephrin expression  
In the kidney, nephrin is expressed only in the podocytes and is mainly localized 
in the SD area [7, 60, 61]. In disagreement with the initial reports, expression of 
nephrin is not limited to the kidney, but can also be found in the testis [10], CNS 
[5], pancreas [5, 11, 62], placenta [63] and lymphoid tissues [64]. The role of 
nephrin in each of these tissues remains elusive, but most likely reflects some 
shared functions. One study in human states that nephrin expression is restricted 
only to the kidney and that CNF patients do not have complications in extra-renal 
organs [65]. However, early nephrectomy and dialysis treatment is clinically used 
to prevent early lethality in CNF patients [44]. This treatment comes along with a 
massive life-long anti-rejection therapy which is needed to modulate the 
immunoreaction against the transplant. Thus, even if initially removing the 
symptoms [45] it is still premature to conclude that no later onset symptoms could 
occur, as other tissue sites could not express nephrin. As described elsewhere in 
this thesis, many of the patients show signs of neurological symptoms [66], which 
interestingly is not a common site of an immunological reaction. Thus, symptoms 
from extra-CNS expression sites of nephrin may be controlled by strong 
immunomodulatory medications. 
3.1.4.1. Alternative nephrin promoter 
An alternative nephrin promoter directs tissue-specific expression of nephrin [67] 
and different transcription factors most likely have tissue- and function specific 
roles in the modulation of NPHS1 gene expression [68-72]. An upstream segment 
of mouse nephrin promoter, between 4 kb and 4 bp, was shown to be sufficient 
for driving expression in the kidney, CNS and pancreas [67]. Surprisingly, these 
studies showed that a 5.7 kb construct lacking the transcription initiation site and 
the immediate upstream region of the gene still drove expression in the CNS. This 
lead to the identification of a novel, additional exon 1B in the mouse NPHS1 gene 
located 1.8 kb upstream from the ATG translation initiation codon of the 
previously known first exon, now termed exon 1A. The existence and functionality 
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of exon 1B was verified in nephrin KO mice in which exon 1A is deleted. Neither 
nephrin mRNA or nephrin protein was observed in the kidneys of the KO mice. 
However, immunohistochemical staining of brain sections from newborn KO mice 
using antibody against the intracellular part of the mouse nephrin, showed similar 
distribution of nephrin protein in the brains of the KO mice compared to wild-type 
controls (WT). These results indicate that KO mice still express nephrin in the 
brain through exon 1B [67]. Deletion of exon 1B and its immediate surrounding 
sequence abolished the expression of the transgene in the pancreas and the 
spinal cord, but not in the kidney and brain in transgenic mice [67]. The function of 
exon 1A is to form the aminoterminal signal sequence, which is cleaved by a 
peptidase in the lumen of the endoplasmic reticulum [4]. In the variant form of 
nephrin with exon 1B this signal sequence does not exist [67]. The biological role 
of the two nephrin isoforms in the brain and kidney remains to be clarified.  
3.1.4.2. Bidirectional nephrin promoter and alternative splicing 
Nephrin also shares a bidirectional promoter area with another immunoglobulin 
superfamily protein, nephrin-like protein 3 (Neph3, Kirrel2 or filtrin), and these two 
genes are transcribed in opposite directions [73]. Nephrin is also regulated by a 
post-transcriptional mechanism. One alternative splicing variant for nephrin 
protein has been reported in humans [60] and four variants in rats [74]. According 
to sequence analysis of two rat variants, nephrin α/β, could be translated into 
correct open reading frames [60]. When compared to the human sequence, α-
nephrin lacks the transmembrane domain encoding for exon 24 and the 
intracellular exons 25, 26 and 27, and β-nephrin lacks part of exon 24 (bp 3166 – 
3205) [35]. The α-nephrin protein, was also found to be expressed in humans, but 
in contrast to rat variant, it lacks only the transmembrane-encoding exon 24 [60]. 
The role of a bidirectional promoter and the alternative splicing variants remains 
to be elucidated. 
3.1.4.3. Endogenous nephrin antisense transcript 
An endogenous antisense transcript originating from the nephrin-encoding locus 
was found when studying the nephrin-deficient mouse-line generated by the 
gene-trapping technique [6]. Further evidence of the antisense transcript 
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(NPHS1as) was obtained by searching for NPHS1-like expressed sequence tags 
[75]. Surprisingly, one clone showed exact sequence similarity compared to the 
NPHS1 transcript, but spanning from exons 7 to 12 in the reverse orientation. 
NPHS1as is expressed in the mouse brain, thymus, peripheral lymph nodes and 
embryonic stem (ES) cells. However, the mesenteric lymph nodes and the main 
sites of nephrin expression, the kidney and pancreas, were negative. The relative 
amounts of sense and antisense mRNAs as well as nephrin protein were 
determined by semiquantitative RT-PCR and immunoblotting in various mouse 
tissues. These results suggest that NPHS1as may be important for the regulation 
of the tissue- and cell-type-specific expression of nephrin. 
3.1.5. Nephrin KO mice die perinatally and show kidney abnormalities 
Two different nephrin KO mouse-lines have been generated by using different 
cloning techniques (See Chapter 5). Consistent with the human CNF disease 
phenotype, nephrin KO mice die within a few days after birth and the podocytes 
show morphological abnormalities closely similar to the glomeruli of CNF patients 
[5, 6]. 
3.1.5.1. Nephrin KO mouse-line generated by homologous recombination 
The first published nephrin KO mouse-line was generated by inactivating the 
NPHS1 gene in ES cells by homologous recombination using a targeting vector. 
In this case exon 1 was fused in-frame to the Escherichia coli lacZ gene located in 
a cassette with, the phosphoglycerine kinase promoter driving the neo selection 
gene, which is transcribed in the opposite direction. Mice homozygous for 
inactivated NPHS1 were born at an expected Mendelian frequency of 25%. 
Although seemingly normal at birth, they immediately developed massive 
proteinuria and oedema and died within 24 h. The kidneys of KO mice exhibited 
enlarged Bowman's spaces, dilated tubules, effacement of podocyte foot 
processes and absence of the SD, essentially as found in human CNF patients 
[5].  
3.1.5.2. Nephrin KO mouse-line generated by random mutagenesis 
The second nephrin KO mouse-line was generated by the gene-trapping 
technique using random insertional mutagenesis [6]. In this method, mouse ES 
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cells are electroporated with the promoterless splice-acceptor type vector, 
PT1βgeo [76], and selected by gentamycin treatment. Resistant clones are 
isolated, and the site of integration is determined by 5'RACE [77]. The sequence 
obtained from 5'RACE revealed integration of the trap vector in an inverted 
orientation in exon 8 of the NPHS1 gene corresponding to the third Ig-motif of the 
extracellular domain of nephrin [6]. Chimeric mice were generated by blastocyst 
injection of the trapped nephrin clone. Southern blot analysis using a lacZ probe 
showed a single integration of the gene-trap vector within the NPHS1 gene [6].  
Nephrin deficient pups died instantly after birth. One homozygote survived 
for 7 d, but it was significantly smaller than the other pups and showed severe 
proteinuria of > 20 mg/ml. Kidneys of nephrin KO mice showed characteristic 
features of proteinuric disease including fibrotic and hypercellular glomeruli as well 
as excessive extracellular matrix deposition. The Bowman’s capsules and tubules 
were dilated, and tubules had severe cystic lesions. Despite the observed 
morphological changes in kidneys of nephrin KO newborn littermates, no 
prominent changes in the branching morphogenesis of the developing collecting 
ducts could be found compared to WT mice. Immunohistochemical staining 
showed that the expression and localization of other SD-associated proteins i.e. 
CD2-associated protein (CD2AP) and zonula occludens-1 (ZO-1) protein were 
unchanged. Electron microscopy revealed that over 90% of the podocyte foot 
processes were fused. The remaining inter-podocyte junctions lacked SDs but 
showed tight adhering areas. Interestingly, in the heterozygote phenotype 
approximately one third of the foot processes are fused, in addition down-
regulation of nephrin-specific mRNA levels occurs [6].  
3.2. Nephrin associated proteins 
Following the identification of nephrin and the characterization of nephrin’s role as 
a key molecule in the filtration barrier, it has become important to identify the 
molecular complexes associated with nephrin and the physiological function of 
this molecular machinery. These proteins can be subdivided into scaffold proteins 
or signaling proteins. 
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3.2.1. Scaffold proteins 
Scaffold proteins are structural proteins forming adherens junction and 
participating in the SD formation between two foot processes. A hypothetical 
representation of selected key-protein components of the SD is shown in Figure 3 
according to the current literature. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A hypothetical representation of the protein components of the SD according to the 
current literature. 
3.2.1.1. Densin 
The densin protein was first reported from a postsynaptic density (PSD) fraction of 
rat forebrain [78]. Recently, densin has been reported also in podocytes of the rat 
kidney [79] and in beta-cells of the islets of Langerhans in the human pancreas 
[80]. The densin gene (LRRC7) is located on human chromosome 1p31.1.  
The protein sequence of densin contains 17 leucine-rich repeats, a 
sialomucin domain, an apparent transmembrane domain, and a PSD-95/Dlg-
A/ZO-1 (PDZ) domain. PDZ domains were first identified in the postsynaptic 
density protein 95 (PSD-95), the Drosophila melanogaster discs large protein 
(Dlg) and the zonula occludens 1 protein (ZO-1) contract to form the name PDZ 
according to the first letters of these proteins. PDZ domain consists of 
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approximately 90 residues and has conserved structural elements, that are 
present as single or repeated copies in a variety of proteins [81]. In addition, the 
PDZ domain functions as a protein-protein interaction module, and is known as a 
central organizer of protein complexes at the plasma membrane [81]. The 
arrangement of densin protein domains is similar to several other adhesion 
molecules including erbin, scribble and lano [82-84]. The molecular weight of 
densin detected in rat brain was 180 kDa [78] and in rat kidney lysate 210 kDa 
[79]. This difference suggests post-translational modification or alternative splicing 
of densin in different tissues [79, 85, 86]. 
In rat brain, densin participates in specific adhesion between presynaptic 
and postsynaptic membranes at glutamatergic synapses and has interactions with 
alpha-actinin-4 [78, 87]. Furthermore, densin was co-immunoprecipitated with 
delta-catenin/neural plakophilin-related armadillo repeat protein and N-cadherin in 
the rat brain [88]. In rat kidney, densin localizes particularly in the SD and appears 
to interact with nephrin [79], however a direct interaction has not yet been proven. 
In addition to cell-cell contact, densin plays roles in signal transduction [89] and 
maintaining cell polarity [90]. Furthermore recent data from the kidney, show that 
there is an interaction between densin and ß-catenin in the podocytes [91]. 
No densin deficient mouse-lines or clinical data concerning mutations in 
the densin gene have been published to date. However, increased densin mRNA 
and protein expression, but reduced glomerular immunostaining has been 
detected in CNF patient’s glomeruli compared to healthy subjects [79]. This 
apparent controversy may reflect an abnormal distribution and localization of 
densin, in the severely distorted and flattened podocytes, in CNF glomeruli 
missing the nephrin backbone for proper anchoring. With missing feedback 
control, this leads to an overproduction and dispersed localization of densin within 
the podocyte, in addition to the functional association with nephrin [79]. 
3.2.1.2. Neph-proteins 
Neph-proteins are expressed in multiple tissues including kidney, testis, CNS, 
pancreas and lymph nodes [73, 92, 93]. Genes expressing Neph1, Neph2 and 
filtrin are Kirrel1 (1q21-25), Kirrel3 (11q24) and Kirrel2 (19q13.12), respectively. 
Interestingly, filtrin and nephrin genes are located in an adjacent genetic locus 
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and they share a partially over lapped promoter sequence, but are expressed in 
opposite directions [73]. Neph1, Neph2 and filtrin are all transmembrane proteins 
that belong to the Ig superfamily with different numbers of extracellular Ig-like 
domains and intracellular parts with signaling capabilities [73, 92, 93].  
The extracellular domain of nephrin has been shown to interact with Neph1 
[53, 54, 93]. Neph1 interacts also with other SD proteins like podocin [93] and ZO-
1 [94]. ZO-1 binding was associated with a strong increase in tyrosine 
phosphorylation of the cytoplasmic tail of Neph1 and dramatically accelerated the 
ability of Neph1 to induce signal transduction [94]. All three Neph proteins share a 
conserved podocin-binding motif and a mutation of a centrally located tyrosine 
residue dramatically lowers the affinity of Neph1 for podocin [93]. Neph2 forms 
homodimers and specifically interacts with the extracellular domain of nephrin in 
vitro and in vivo [95]. Neph1 however fails to interact with Neph2. Immunoreactive 
Neph2 has been detected in the urine of healthy subjects, suggesting that the 
extracellular domain is cleaved under physiological conditions [95]. These findings 
were confirmed in vitro in podocyte cell culture. Cleaving was increased by 
tyrosine phosphatase inhibitors and diminished by GM6001, an inhibitor of 
metalloproteinases. These findings suggested a role for Neph2 in the organization 
and/or maintenance of the glomerular SD that may differ from the functions of 
Neph1 and nephrin [95]. Interaction partners for filtrin are not yet known. 
Neph1 KO mice generated by the gene-trapping approach were 
represented at the expected normal Mendelian ratios at one to three days of age 
but at only 10% of the expected frequency at 10 to 12 days after birth, suggesting 
an early postnatal lethality [92]. The Neph1 KO mice that survived beyond the first 
week of life were sick and small but without oedema, and all died between three 
and eight weeks of age. All Neph1 KO mice showed severe proteinuria and 
podocyte foot processes effacement. Three-weeks-old Neph1 KO kidneys 
exhibited dilated juxtamedullary glomeruli, diffuse mesangial hypercellularity, and 
increased mesangial matrix and occasional mesangiolysis. Kidneys from newborn 
Neph1 KO mice showed occasional cystic glomeruli, dilated proximal tubules lined 
by epithelial cells that in some cases contained vacuoles and/or protein droplets, 
and protein-filled tubules. These findings suggest that Neph1, like nephrin, may 
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play an important role in maintaining the structure of the filtration barrier, which 
prevents proteins from freely entering the glomerular urinary space [92]. 
Recently, the relevance of glomerular expression of filtrin in human 
glomerular diseases was demonstrated in patients with focal segmental FSGS 
[96]. These patients filtrin mRNA level was only one-tenth compared to samples 
from the kidneys of healthy controls. In addition, changes in the expression 
pattern of filtrin in renal biopsies were found by immunostaining. However, no 
correlation between the expression of filtrin and the levels of serum creatinine and 
proteinuria was observed. These results indicate a potential role of down-
regulation of the filtrin gene and protein expression in the pathogenesis of 
proteinuric diseases. 
3.2.1.3. Podocin 
Podocin protein has been shown to be expressed only in the podocytes [26] and 
has been localized in the SD [97]. A gene encoding podocin, NPHS2, is mapped 
to chromosal locus 1q25-31 [26]. NPHS2 gene is mutated in autosomal recessive 
steroid-resistant nephrotic syndrome [26] and in some patients with a phenotype 
of CNF but without mutations in nephrin [98].  
The podocin protein presents similarities with proteins of the stomatin 
family and is predicted to be an integral membrane protein of 383 amino acids, 
with a single membrane domain forming a hairpin-like structure and with both N- 
and C-terminal domains in the cytosol [26]. The structure and the subcellular 
localization of the podocin indicates it’s role as a linker between the components 
of the SD and the actin cytoskeleton [97]. 
Podocin interacts with the intracellular domain of nephrin [99]. Podocin has 
been shown to interact also with CD2AP [99] and Neph1 [93]. Podocin is 
anchored in lipid rafts, which are microdomains rich in sphingolipids and 
cholesterol in the outer leaflet of the plasma membrane [100]. Nephrin and Neph1 
are also found in these lipid rafts, where they associate with podocin and form a 
transmembrane receptor complex [53, 99, 100]. Interestingly, interaction with 
podocin affects the signaling properties of nephrin and nephrin-induced signaling 
is greatly enhanced by podocin binding [101]. Furthermore, when the tyrosine 
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kinase Fyn phosphorylates tyrosine residues in the cytoplasmic domain of 
nephrin, it leads to enhanced association with podocin and downstream signaling 
of nephrin [102].  
In the recent study, the RNA interference (RNAi) expression vector against 
podocin mRNA was generated and transfected into a mouse podocyte cell-line 
[103]. The results showed decreased podocin and nephrin mRNA and protein 
levels. The distribution and the mRNA and protein level of alpha-actinin-4 showed 
no appreciable change. Alpha-actinin-4 localized mainly in the cytoplasm and also 
extended to the processes. These results suggested that podocin may interact 
directly with nephrin, but not with alpha-actinin-4.  
A podocin KO mouse-line was generated by inactivating the NPHS2 gene 
in ES cells by homologous recombination [104]. These mice developed proteinuria 
during the early antenatal period and died in the first five weeks of life due to renal 
failure caused by massive mesangial sclerosis. Electron microscopy revealed 
extensive fusion of podocyte foot processes and lack of a SD in the remaining foot 
process junctions. Also, the expression of the nephrin gene was downregulated, 
whereas that of the ZO-1 and CD2AP genes appeared to be upregulated. These 
findings demonstrate the crucial role of podocin in the establishment of the 
glomerular filtration barrier. 
3.2.1.4. CD2AP 
CD2AP was first found in mouse T cells interacting with the cell adhesion protein 
CD2, but is broadly expressed and found in all tissues except CNS [105]. The 
CD2AP gene is located on human chromosome 6p12. Two human patients with 
focal segmental glomerulosclerosis had a mutation predicted to ablate expression 
of one CD2AP allele, implicating CD2AP as a determinant of human susceptibility 
to glomerular disease [106]. 
The CD2AP protein contains three amino-terminal Src homology 3 (SH3) 
domains followed by a proline-rich region and a coiled-coil domain at the carboxyl 
terminus [105]. The SH3 domain has been described on several cytoskeletal and 
signaling proteins, where it mediates protein–protein binding to proline-rich 
regions [107].  
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CD2AP was the first identified protein interacting with the intracellular 
domain of nephrin [108-111]. Other studies however, have presented 
controversial data that does not support the interaction between nephrin and 
CD2AP [101, 112]. CD2AP has been suggested to act as an adaptor protein 
between other proteins and the actin cytoskeleton [52, 111, 113-115]. 
Mice lacking CD2AP were generated by homologous recombination [108]. 
Homozygous CD2AP KO mice were born with a normal Mendelian frequency of 
25%. At three weeks of age, CD2AP KO animals began to exhibit substantial 
growth retardation, and most KO mice died at six to seven weeks of age. 
Postmortem examination of these mice revealed cardiac hypertrophy, splenic and 
thymic atrophy, and ascites. Histological examination revealed evidence of severe 
kidney pathology including defects in podocyte foot processes, accompanied by 
mesangial cell hyperplasia and extracellular matrix deposition. This pathology 
correlated with proteinuria, elevated blood urea nitrogen and creatinine 
concentrations, and reduced serum albumin concentrations, all signs of kidney 
dysfunction. Proteinuria was first detected at approximately two weeks of age 
[108]. Interestingly, mice heterozygote for CD2AP deficiency, also developed 
glomerular changes at nine months of age and had increased susceptibility to 
glomerular injury by nephrotoxic antibodies or immune complexes [106].  In these 
mice, defects in the formation of multivesicular bodies in podocytes were found by 
electron microscopic analysis, suggesting an impairment of the intracellular 
degradation pathway. 
Although CD2AP protein is widely expressed, the severity of renal failure 
precludes a clear determination of the role of CD2AP in other tissues. Recently, 
transgenic mouse-line expressing CD2AP under the control of the nephrin 
promoter [116] was generated and cross-bred with a CD2AP KO mouse-line 
[108]. Podocyte-specific expression of CD2AP prevented the development of 
proteinuria, demonstrating that the renal failure is solely due to loss of CD2AP in 
podocytes and not in other renal or immune cells [117]. Rescued CD2AP KO mice 
were long-lived and phenotypically normal. Interestingly, rescued CD2AP KO 
male animals were infertile and histological analysis demonstrated testicular 
abnormalities that were age-related. This suggests that CD2AP also plays an 
important role in the development of sperm in the testes. CIN85, one of  paralogs 
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of CD2AP, is poorly expressed in both the podocyte and the basal seminiferous 
tubule, suggesting that loss of CD2AP protein expression in specific tissues may 
be compensated for by CIN85 [117]. 
Furthermore, combinations in mice with CD2AP heterozygosity and 
heterozygosity of either synaptopodin or Fyn but not Neph1 resulted in 
spontaneous proteinuria and in FSGS-like damage [118]. This result was 
explained by protein interactions, where CD2AP associates with Fyn and 
synaptopodin but not with Neph1. It also demonstrates that bigenic heterozygosity 
can lead to FSGS and suggests that combined mutations in podocyte genes may 
be a common etiology for glomerular disease.  
3.2.1.5. ZO-1 
The tight junction protein ZO-1 was the first protein found in the cytoplasmic base 
of the SD area [48]. ZO-1 is expressed in multiple tissues including testis, CNS 
and pancreas [119-121]. The gene encoding ZO-1, TJP1, is located on human 
chromosome 15q13. The ZO-1 protein is a member of the membrane-associated 
guanylate kinase homologue protein family (MAGUK) [122]. MAGUK proteins are 
composed of modular units including a PDZ domain, a SH3 domain, a guanylate 
kinase domain and a proline-rich moiety [122]. These domains have been shown 
to function in binding integral membrane proteins such as ion channels at 
synapses [123, 124]. In addition, the guanylate kinase domain has been shown to 
bind a novel synaptic protein [125], and the SH3 domain of ZO-1 binds a serine 
protein kinase that phosphorylates a region at the COOH-terminal end of the 
protein [126]. 
ZO-1 interacts with many different cell-junction components including 
occludin, alpha-catenin and ZO-2 as well as with the cytoskeletal molecules 
spectrin and F-actin [127]. The role of ZO-1 in the SD remained unclear until the 
interaction between ZO-1 and Neph1 was reported [94]. These results show that 
ZO-1 may serve as a cytoplasmic organizer by coupling the nephrin-Neph1 
complex to the actin cytoskeleton and recruiting appropriate signal transduction 
components to the SD area.  
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Although no ZO-1 KO mouse-line has been published some in vivo data 
are available. Alterations in ZO-1 localization and expression have been observed 
in puromycin aminonucleoside and in protamine sulphate induced nephropathy in 
rats [128]. These changes were inhibited by cyclosporine A administration [129]. 
However, in CNF patient kidneys ZO-1 expression remains unaffected [130]. In 
podocin KO mice, the expression of the nephrin gene was downregulated, 
whereas that of the ZO-1 and CD2AP genes appeared to be upregulated [104]. 
Recently, decreased expression of ZO-1 in glomeruli and redistribution of ZO-1 
from the podocyte membrane to the cytoplasm has been shown in diabetic 
animals, and in glomerular epithelial cells after high glucose treatment [131]. In 
the same study, it was shown that serine and tyrosine phosphorylation of ZO-1 
was decreased in cells exposed to high glucose. These findings suggest that 
alterations in the content and localization of ZO-1 may be relevant to the 
pathogenesis of proteinuria in diabetes [131]. 
3.2.1.6. Alpha-actinin-4 
Alpha-actinin-4 is ubiquitously expressed and also reported to be present in 
podocytes [28]. The ACTN4 gene is closely located in the same human 
chromosome 19q13 as the NPHS1 gene. Mutations in ACTN4 lead to an 
inheritable form of glomerulosclerosis [28]. 
The alpha-actinin-4 protein is an actin-bundling protein [28]. It has also  
been shown to interact with densin in rat brain [78, 87]. Recently, interaction of 
alpha-actinin-4 with ZO-1 was confirmed by co-immunoprecipitation in various 
tissues including brain, liver and heart [132]. In RNAi studies in vitro, nephrin, 
podocin, or CD2AP silencing did not change the expression of alpha-actinin-4, 
whereas silenced alpha-actinin-4 downregulated nephrin and upregulated podocin 
and CD2AP [112].  
A transgenic mouse-line, which expressed murine alpha-actinin-4 
containing a mutation analogous to that affecting a human FSGS family in a 
podocyte-specific manner was previously generated [133]. Consistent with the 
association of human alpha-actinin-4 in FSGS, a proportion of the transgenic mice 
exhibited significant albuminuria. Only proteinuric mice exhibited histological 
features consistent with human alpha-actinin-4-associated FSGS, including 
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segmental sclerosis and tuft adhesion of some glomeruli, tubular dilatation, 
mesangial matrix expansion, as well as regions of podocyte vacuolization and foot 
process fusion. Consistent with such podocyte damage, proteinuric alpha-actinin-
4 mutant mouse kidneys exhibited significantly reduced nephrin mRNA and 
protein. These results suggest a relationship between dysregulation of actin 
cytoskeleton in the mutant alpha-actinin-4 mouse and consequent deterioration of 
the nephrin-supported SD complex [133]. 
An alpha-actinin-4 KO mouse-line was generated by homologous 
recombination [134]. The number of mice homozygous at birth was lower than 
expected under Mendelian inheritance indicating embryonic lethality. Surviving 
homozygous KO mice showed progressive proteinuria, glomerular disease, and 
pups typically died at several months of age. Light microscopic analysis revealed 
extensive glomerular disease and proteinaceous casts in the tubules. Electron 
microscopic examination showed foot-process effacement in young mice and 
diffuse effacement with globally disrupted podocyte morphology in older mice. 
Interestingly, despite the widespread distribution of alpha-actinin-4, histological 
examination of mice showed abnormalities only in the kidneys [134]. However, the 
mechanism by which alpha-actinin-4 deficiency leads to glomerular disease has 
not been clarified. 
Recently, the effect of alpha-actinin-4 deficiency on the adhesive properties 
of podocytes was examined further [135]. A comparison with alpha-actinin-4-KO 
mice to WT controls, showed a decrease in the number of podocytes/glomerulus 
as well as the presence of podocyte markers in the urine. Podocyte cell-lines 
generated from alpha-actinin-4 KO mice were less adherent to GBM components 
collagen IV and laminin 10 and 11 than cells from WT mice. Furthermore, the 
strength of the integrin receptor-mediated linkages to the cytoskeleton was tested 
by applying force to microbeads bound to integrin using magnetic pulling 
cytometry. Beads bound to alpha-actinin-4 KO podocytes showed greater 
displacement in response to the applied force than those bound to WT cells. 
Consistent with integrin-dependent alpha-actinin-4-mediated adhesion, 
phosphorylation of beta1-integrins on alpha-actinin-4 KO podocytes was reduced. 
These results suggest that alpha-actinin-4 interacts with integrins and strengthens 
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the podocyte-GBM interaction thereby stabilizing glomerular architecture and 
preventing disease [135].  
3.2.2. Signaling proteins 
Nephrin has been suggested to have a role in intracellular signaling and in 
regulating the actin cytoskeleton of podocytes. The hypothetical nephrin-
associated signaling molecules and pathways are presented in Figure 4 according 
to the current literature. 
 
 
 
 
 
 
 
 
 
 
Figure 4. A hypothetical representation of the nephrin-associated signaling molecules and 
pathways according to the current literature. A) The nephrin-Nck signaling pathway participates in 
actin polymerization and foot process formation. B) The nephrin-CD2AP-PI3K signaling pathway 
participates in the protection against apoptosis and in foot process maintenance. 
3.2.2.1. TRPC6 
The member 6 of the transient receptor potential cation channel subfamily C 
(TRPC6) has recently been localized in the podocyte cell membrane [136], but is 
also expressed in many other tissues. The TRPC6 gene is located on human 
chromosome 11q21-22 and a mutation in TRPC6  was identified as a causative 
factor for a familial form of FSGS [27]. The TRP family of calcium channels 
contains over 50 members that serve a large number of cellular functions [137]. 
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For channels containing TRPC6 subunits, the stimulus for calcium influx seems to 
be the second messenger diacylglycerol [138].  
In podocytes, TRPC6 associates with nephrin and podocin, but not with 
CD2AP [136]. TRPC6 shares similarities to the nephrin cytoplasmic domain as it 
appears to be regulated by Fyn tyrosine phosphorylation [139]. Recently, it has 
been shown that TRPC6 is functionally connected to the podocyte actin 
cytoskeleton that is rearranged upon over-expression of TRPC6 [140]. 
Furthermore the induced expression of TRPC6 is also a common feature of 
human proteinuric kidney diseases, with the highest induction observed in 
membranous nephropathy [140]. In this study, cultured podocytes were exposed 
to complement and upregulation of TRPC6 protein was observed. Moreover, 
stimulation of receptor-operated channels by 1-oleoyl-2-acetyl-sn-glycerol in 
puromycin aminonucleoside-treated podocytes led to an increased calcium influx 
in a time- and dosage-dependent manner. In addition, a transient in vivo gene 
delivery of TRPC6 into mice led to expression of TRPC6 protein at the SD and 
caused proteinuria. These studies suggest the involvement of TRPC6 in the 
pathology of non-genetic forms of proteinuric disease, but its function and 
mechanism of action remains unresolved [140].  
The TRPC6 KO mouse-line has been generated by homologous 
recombination [141]. TRPC6 KO mice were viable and showed normal phenotype. 
Fertility and litter sizes were similar compared to WT mice. Based on the previous 
data, the loss of TRPC6 function was predicted to lead to a loss of vascular 
smooth muscle tone and attendant hypotension. Unexpectedly, a higher agonist-
induced contractility in isolated aortic rings and an elevated systemic blood 
pressure was observed in these mice. These effects were explained by in vivo 
replacement of TRPC6 by channels of the TRPC3 type, a closely related but 
constitutively active member of the diacylglyserol-activated TRPC3/6/7 family 
[141]. A kidney phenotype of the TRPC6 KO mouse-line has not been reported. 
3.2.2.2. Fyn 
The Src family kinase Fyn has also been localized in the podocytes [58]. The Fyn 
gene is located on human chromosome 6q21. The Fyn protein contains SH2 and 
SH3 domains, both of which are capable of binding to nephrin. Moreover, Fyn 
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contains a tyrosine kinase domain that is capable of phosphorylation of tyrosine 
residues in target proteins [58].  
Nephrin has several intracellular tyrosine residues, some of which are 
modified by phosphorylation in response to nephrin clustering [142]. These 
tyrosine residues can be phosphorylated by Fyn, which binds to nephrin most 
likely via its SH3 domain [58, 102]. Phosphorylation is a biologically important 
modification of target proteins. It allows the binding of different adaptor proteins to 
receptor complexes, which then conveys downstream signal transduction to other 
proteins [143]. 
Fyn KO mice excreted normal levels of albumin at all ages tested and had 
a median life span of more than 60 weeks [144]. Histologically Fyn KO mice 
kidneys were not different from WT mice at any age studied. Further studies with 
this same mouse-line showed that neither Fyn KO or Yes KO mice (another 
member of the tyrosine kinase family) developed proteinuria as followed up to 11 
months post-gestation [58]. In contrast, double KO mice for both Fyn and Yes 
developed significantly increased albuminuria at the age of four weeks and their 
kidneys showed a severe phenotype compared to single KO mouse-lines [58]. 
The renal histology of Fyn KO and Yes KO mouse-lines was indistinguishable 
from that of age-matched WT controls. In contrast, kidneys of double KO mice 
exhibited mesangial expansion and hypercellularity that was readily detectable. In 
electron microscopy studies, the podocyte foot processes of Fyn KO mice were 
structurally distorted or coarsened but in some cases retained apparent SDs. 
Many Fyn KO podocytes appeared entirely "effaced" forming a confluent epithelial 
mass with the absence of structurally typical SDs. Fyn KO glomeruli also 
demonstrated mesangial expansion with mild mesangial hypercellularity and a 
modestly increased mesangial matrix. Yes KO mice displayed a glomerular 
histology indistinguishable from that of WT age-matched littermates [58]. 
Glomeruli of FynYes double KO mice demonstrated a distinct and more severe 
phenotype [58, 144]. In addition, glomerular capillary endothelial swelling and 
disruption were evident in double KO mice[58]. 
Furthermore, glomeruli in Fyn, Yes, or double KOs were characterized to 
explore the relationship between these kinases and nephrin [58]. Fyn deletion 
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resulted in coarsening of podocyte foot processes and marked attenuation of 
nephrin phosphorylation in isolated glomerular detergent-resistant membrane 
fractions. Yes deletion had no identifiable effect on podocyte morphology but 
dramatically increased nephrin phosphorylating activity. Similar to Fyn deletion, 
simultaneous deletion of Fyn and Yes reduced nephrin phosphorylation activity. 
These results demonstrate that endogenous Fyn catalyzes nephrin 
phosphorylation in podocytes. Although Yes appears to affect the regulation of 
nephrin phosphorylation, the mechanism by which this occurs requires further 
investigation [58]. 
Also combinations of mice with CD2AP heterozygosity and Fyn 
heterozygosity resulted in spontaneous proteinuria and in FSGS-like glomerular 
damage. This result was explained by protein interactions and demonstrates that 
combined mutations in podocyte genes may be a common etiology for glomerular 
disease [118].  
3.2.2.3. Nck adaptor proteins 
Mammals have two Nck adaptor family members (Nck1/α and Nck2/ß, also 
termed Grb4). The genes Nck1 and Grb4 are mapped to chromosal locus 3q21 
and 2q12, respectively [145]. The two murine Nck proteins share 68% amino acid 
identity with most of the sequence variation being located in the linker regions 
between the SH3 and SH2 domains, and are 96% identical to their human 
counterparts [146]. Nck adaptor proteins consist of three SH3 domains, followed 
by a C-terminal SH2 domain that binds optimally to pYDEP/D/V motifs in target 
proteins [147]. Both Nck1 and Nck2 have been shown to be expressed in 
podocytes [9]. 
Recently, the importance of nephrin in regulating the actin cytoskeleton in 
podocytes via Nck adaptor proteins has been shown [8, 9, 148, 149]. The 
cytoplasmic tail of nephrin has conserved tyrosine-contained motifs (YDxV) that 
are capable of binding to the SH2 domain of the Nck1 adaptor protein after 
phosphorylation by Src-family tyrosine kinases, e.g. Fyn [8, 9]. It has been shown 
that the tyrosine amino acids numbers 1776-Y and 1193-Y are crucial for the 
interaction of nephrin to Nck1 in humans [8]. Interestingly, one of the two tyrosine 
motifs needed for Nck1 binding in humans (1176-YDEV) and mice (1191-YDEV) 
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has not been conserved in rats (1187-HDEV) [8, 9, 59] (Figure 2B). The Nck1 
SH3 domains has been shown to bind selectively to proteins that control 
cytoskeletal organization including Wiskott Aldrich syndrome gene like (N-WASP) 
[150], WASP-interacting protein [151], and the WAVE1 complex [152]. N-WASP 
and WAVE1 interact through their C termini with the Arp2/3 complex in a fashion 
that promotes actin branching and polymerization [153]. Nck1 can bind directly 
through each of its SH3 domains to N-WASP, and this co-operative binding can 
stimulate N-WASP-Arp2/3-mediated actin polymerization in vitro [154]. Less is 
known about the binding properties and biological function of Nck2, although 
these are supposed to be rather similar to Nck1 [155]. Nck2 selectively interacts 
through its third SH3 domain with the LIM4 domain of PINCH, a protein involved in 
integrin signaling [156]. In addition, the Nck2 SH2 domain specifically binds to 
tyrosine phosphorylated B-type ephrins and links B-ephrin reverse signaling to 
cytoskeletal regulatory proteins [157]. Nck2 has also been proposed to have a 
unique role in linking the ß-platelet-derived growth factor-receptor to actin 
polymerization in mouse NIH 3T3 fibroblast [158]. 
In the rat model of podocyte injury and proteinuria, nephrin tyrosine 
phosphorylation and nephrin–Nck1 interaction were both reduced significantly 
[148]. Mice lacking either Nck1 or Nck2 are viable and show no apparent renal 
defects, suggesting compensation between the subclasses [159]. Double KO 
mice for both Nck1 and Nck2 died at embryonic day 9.5, precluding analysis of 
Nck function in podocytes of double-null animals [159]. A mouse-line where Nck2 
expression was selectively deleted in podocytes of Nck1 KO animals by 
expressing Cre recombinase under the control of the podocyte-specific podocin 
promoter has been developed [9]. These mice at four days of age were smaller 
than control littermates, and this growth retardation was more apparent at three 
weeks of age [9]. These mice showed proteinuria and proteinaceous material 
within the tubules. Most individual glomeruli remained relatively normal in the first 
few weeks of life, but at three and half weeks of age a range of glomerular defects 
were detected that include focal sclerosis. Furthermore the expression of 
molecular markers of glomerular development (Wilm's tumour-1 (WT1) and 
nephrin) in the glomeruli of Nck KO mice was comparable to littermate controls at 
one week of age but was reduced by three and half weeks of age, indicating a 
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loss of podocytes. Electron microscopy examination of kidneys from four-days-old 
pups showed complete fusion of foot processes of fully differentiated glomeruli in 
Nck KO animals. Interestingly in glomeruli from both mutant and control embryos 
(16.5 d), endothelial cell fenestrations were present and podocytes spread 
normally around the capillary loops. However differentiated foot processes were 
notably absent at this stage of development in Nck KO embryos compared to 
controls, consistent with the hypothesis that foot processes fail to form in Nck KO 
mice [9]. Developmental foot process effacement due to loss of Nck in podocytes 
resembles that observed in mice deficient in nephrin [5, 6], as well as other 
proteins of the SD such as Neph1 [92], FAT1 [50] and α3 integrin [160].  
In addition to interacting with Nck, nephrin associates with several 
cytoplasmic proteins at the SD [161], which may modulate the cellular response to 
Nck signaling and foot process effacement formation. The importance of actin 
remodelling in podocyte function is supported by genetic evidence in patients with 
adult-onset FSGS, who carry mutations in alpha-actinin-4 [28]. Through 
interaction with alpha-actinin-4 and the Arp2/3 complex, the cytoplasmic adaptor 
CD2AP has also been proposed to anchor nephrin to the actin cytoskeleton [162]. 
Although mice lacking CD2AP or alpha-actinin-4 develop nephrotic syndrome, 
foot process formation is initiated in these mice [108, 134] in contrast to Nck-
deficient animals, suggesting that this complex might primarily be required for the 
maintenance of podocyte foot processes. The roles of Nck and CD2AP in 
signaling to the podocyte cytoskeleton are therefore likely to be distinct, and it will 
be of interest to explore whether Nck expression is also required in the mature 
glomerular filtration barrier maintenance (Figure 4A). 
3.2.2.4. P13/AKT kinases 
Previously, it has been shown that both nephrin and CD2AP interact with the p85 
regulatory subunit of phosphoinositide 3 kinase (PI3K) in vivo [163].  This binding 
recruit PI3K to the plasma membrane, and together with podocin stimulates PI3K-
dependent v-akt murine thymoma viral oncogene homolog 1 (AKT) signaling in 
podocytes [163]. In other systems, binding of the p85 subunit to the catalytic 
subunit p110 of PI3K further phosphorylates the serine-threonine kinase AKT and 
enhances cell survival by blocking apoptosis [164]. PI3K binding to the 
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cytoplasmic domain of nephrin has been shown to be dependent upon 
phosphorylation by Fyn kinase [163]. PI3K is a heterodimer comprising a 
regulatory subunit p85 and a catalytic subunit p110. Subunit p85 recognizes 
phosphorylated nephrin and allows p110 to phosphorylate phospholipids at the 
inner leaflet of the lipid bilayer stimulating the serine-threonine kinase AKT. 
Further downstream phosphorylation occurs, one such phosphorylated protein is 
the BCL2 antagonist of cell death (BAD), which is a proapoptotic factor. 
Phosphorylation of BAD protects the podocytes from apoptosis induced by 
detachment [163]. This finding has led to the suggestion that inhibition of nephrin 
signaling makes podocytes more susceptible to apoptosis. These findings reveal 
a novel role for the SD proteins nephrin, CD2AP, and podocin suggesting that the 
nephrin-CD2AP-mediated AKT activity can regulate complex biological programs 
like apoptosis and foot process maintenance. However, more studies are needed 
to verify these findings (Figure 4B). 
4. SD protein expression in extra-renal tissues  
Contrary to early assumptions [4], expression of nephrin is not limited to the 
podocytes, but is also present in the testis [10], CNS [5], pancreas [5, 11, 62], 
placenta [63] and lymphoid tissues [64]. Furthermore, many other nephrin-
associated SD proteins have been found in extra-renal tissues.  
4.1. Testis 
It is apparent that protein complexes vital for cell-cell interactions in many organs, 
such as kidney, testis, CNS and pancreas, are composed of the same junction 
protein families that resemble or have modified functions in each organ. In 
mammals, the urinary and reproductive organs also develop from the same 
intermediate mesoderm during the embryogenesis. 
4.1.1. Early organogenesis of the kidney and testis 
Three types of renal organs are found during the organogenesis of mammalian 
species. These structures derived from intermediate mesoderm formed after 
gastrulation, and are called the pronephros, the mesonephros and metanephros. 
In mammals, only the metanephros remain through adulthood whereas the 
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pronephros and mesonephros partly transformed to the developing genital areas 
during embryogenesis [165, 166]. The pronephros consists of a series of 
transverse tubules that are suggested to be important in pronephric-mesonephric 
duct formation. These structures develop into the nephric or Wolffian duct [165, 
166].  
In humans, the mesonephros has already characteristic kidney structure 
similar to that is found in the metanephritic kidney. It consists of glomeruli with a 
well-developed  vasculature, proximal and distal tubules, and collecting ducts 
[165, 166]. In murines, the mesonephros is relatively poorly developed compared 
to humans and starts to regress at the same time as the development of the 
metanephros [165, 166]. In male mice, most of the cranial tubules of the 
mesonephros forms the epidymal ducts of the adult male, while the Wolffian duct 
serves as the vas deferens [165 ].  
The mesonephros and presumptive gonadal area, called the genital ridge, 
are developed next to each other [165]. During the development, there is 
extensive cell migration between the mesonephros and developing testis [167]. 
These cells participate in shaping of seminiferous cords [168, 169] and Sertoli cell 
differentiation [170].  Furthermore, some studies indicate that Sertoli cells [171] 
and Leydig cells [172] might be of mesonephric origin.  
Development of the metanephros includes an outgrowth of the primary 
nephric duct, called the ureteric bud, which extends into the surrounding 
metanephric mesenchyme. Kidney organogenesis includes further branching and 
cell-cell interactions, which finally form adult functional kidneys with highly 
specialized filtration barrier and nephrin protein expression [173]. 
Interestingly, the mesonephros also shares the same key regulatory 
molecules as found in the metanephros and adult kidney including paired box 
gene Pax-2 [174, 175] and WT1 [176, 177]. The mutation in WT1 gene in humans 
causes abnormalities of the urinary tract and genitalia formation [176]. Targeted 
deletion of WT1 gene in mice resulted in embryonic lethality in homozygotes. In 
addition these embryos lacked gonads and most of the mesonehric tubules and 
the metanephros [177]. Inducible PAX2 activation in adult mice decreased WT1 
expression and consequently dramatically reduced expression of nephrin [178]. 
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Nephrin protein expression and nephrin promoter activity is detectable in the 
mesonephros stage and subsequently in the metanephros in late S-shaped 
bodies at embryonic day 13 [4, 5, 59, 61]. Despite the well characterized role of 
nephrin in mature podocytes, its function in the mesonephrogenesis remains 
unknown. 
4.1.2. Sertoli cells show morphological and molecular similarities with podocytes 
In the testis the arrangement of Sertoli cells closely resembles the podocyte 
structure in the kidney. Sertoli cells act as feeder cells for the developing germ 
cells, and constitute the blood-testis barrier that selectively regulates the amount 
of proteins passing through [179]. Sertoli cells shared molecules with podocytes 
including extracellular proteins, such as cadherins, and intracellular scaffolding 
proteins, such as catenins and ZO-1 and ZO-2 [180-185]. Also nephrin has been 
detected in the Sertoli cells of mice [10]. Furthermore, podocyte-specific 
expression of CD2AP protein rescued CD2AP KO mice from embryonic lethality, 
which uncovered a hidden phenotype characterized by infertility and testicular 
abnormalities [117]. Recently, the importance of CD2AP in Sertoli-germ cell 
adhesion to facilitate germ cell migration has been shown [186]. A transcription 
factor for nephrin, WT1, is expressed in mature Sertoli cells [187] and mutations 
in WT1 gene cause infertility and genital abnormalities in both mouse and man 
[188-191]. 
Pubertal development and testicular function have also been reported for 
male CNF patients [65]. Two patients showed low levels of inhibin B, which 
suggests impaired Sertoli cell function. One patient had an increased follicle-
stimulating hormone (FSH) and a decreased inhibin B level with a small right 
testicle. The other patient had a decreased level of inhibin B and markedly 
increased luteinizing hormone (LH) and FSH levels [65]. Inhibin B is a 
glycoprotein produced predominantly by Sertoli cells and regulates pituitary FSH 
release by a negative feedback loop [192]. The regulation of inhibin B is complex 
with changes in the pattern of secretion occurring during development, and many 
factors such as FSH, testosterone, Sertoli cell proliferation and germ cell 
complement are likely to contribute to its overall production. Systemic inhibin B 
concentrations seem to reflect the spermatogenic status with high levels of inhibin 
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B observed in normal, fertile individuals and lower levels of inhibin B in individuals 
with severe damage to the testis as a result of germ cell depletion [192]. 
Cell-cell interactions between Sertoli and germ cells in the testis are crucial 
for mechanical adhesion and tissue morphogenesis. Importantly, these 
interactions play a major role in spermatogenesis that involves a series of 
complex biochemical, molecular and cellular events [193]. However, structural and 
functional aspects with regard to cell-cell interactions between Sertoli cells and 
germ cells are still poorly understood.  
4.2. CNS 
Podocytes share some similarities with neuronal cells. Both cells are highly 
polarized, have a common cytoskeletal organization and a common machinery for 
process formation [194, 195]. They also share several proteins that have 
restricted expression, such as nephrin [5, 59], densin [78], Nck1/2 [159] and many 
others [196-203].  
During development of the CNS, neurons and glia cells are produced from 
common progenitor cells, radial glia cells, in the ventricular zone (VZ) of the 
neural tube [204, 205]. In mouse brain development, nephrin expression has for 
the first time been observed in radial glial cells in the VZ of the fourth ventricle and 
along the entire spinal cord at embryonic day nine [59]. Filtrin expression has 
been localized in the same CNS region as nephrin during the mouse brain 
development at embryonic day 12.5 [206]. Moreover, WT1 is expressed in the 
roof of the fourth ventricle of the brain during mouse development whereas in the 
newborn mouse expression is restricted to the kidney glomeruli [207]. Recently, 
Neph1 and Neph2 have been shown to be expressed in both developing and 
mature mouse brain [203]. Both these proteins showed a similar expression 
pattern during neuronal development starting at embryonic days 12 and 11, 
respectively. Expression of Neph-proteins was strongest in areas of high 
migratory activity as noticed in nephrin and filtrin expression earlier. These 
observations suggest that migrating early postmitotic neural precursors in the VZ, 
might form a neuroepithelial cell-like network with bipolar morphology, and 
communicate with their neighbouring cells through adherens junctions similar to 
podocytes [206].  
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In the newborn mouse brain, nephrin expression was found in the 
cerebellum, glomeruli of the main olfactory bulb, the hippocampal dentate gyrus 
and radial glia cells. This suggest a role for nephrin in granular cell and in Purkinje 
cell migration [5]. However histological analysis did not reveal any apparent 
morphological changes in the cerebellum of newborn nephrin KO mice [5]. In the 
adult mouse brain, Neph1 and Neph2 were predominantly seen in the olfactory 
nerve layer and the glomerular layer of the olfactory bulb, in the hippocampus, 
and in Purkinje cells of the cerebellum [203]. At the ultrastructural level, Neph1 
and Neph2 were detectable within the dendritic shafts of pyramidal neurons. To a 
lesser extent, there was also synaptic localization of Neph1 within the stratum 
pyramidale of the hippocampal CA1 and CA3 region on both pre- and 
postsynaptic sites. There it co-localized with the synaptic scaffolder calmodulin-
associated serin/threonin kinase, and both Neph1 and Neph2 interact with its PDZ 
domain via their cytoplasmic tail [203]. 
Nephrin and Neph1 KO mice die during their first day of life, which hampers 
studies on the potential effects of protein loss on brain development and function. 
Despite the apparent normal development of CNF patients after kidney 
transplantation [208], the role of nephrin in these patients is still unclear. However, 
muscular dystonia, mild ataxia and athetosis in CNF patients have been reported 
[66], but these symptoms may also be a complication of the congenital nephrotic 
syndrome and massive protein loss itself. Nephrin absence in the brain might be 
compensated by other cell adhesion molecules of the immunoglobulin superfamily 
like Neph1, Neph2 and filtrin, which are also expressed in the CNS [203, 206, 
209-211]. The function of nephrin antisense transcript reported in mouse brain 
remains to be clarified in human brain [75]. 
4.3. Pancreas 
Nephrin is expressed in the pancreas, particularly in the insulin producing β-cells 
of the islets of Langerhans [5, 11]. Recently many other nephrin associated 
proteins have been identified in the endocrine part of pancreas, like densin [80], 
filtrin [73, 80, 212], FAT, alpha-actinin-4 [213] and ZO-1 [214, 215]. Also podocin 
and CD2AP have been found in the pancreas, but these are more likely to be 
expressed in the exocrine part [213]. Interestingly, the podocin protein detected 
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by immunoblotting was smaller than the fragment found in the kidney [213]. This 
might indicate unspecific binding of the antibody, an unknown tissue-specific 
splicing variant or different post-translational modification of the podocin protein in 
the pancreas.  
The precise role of nephrin and its associated protein complex in the 
pancreas still remains unsolved. There are no reports of CNF patients, who 
developed diabetes before or after kidney transplantation. In addition, in glucose 
tolerance tests, CNF patients after kidney transplantation did not show any 
difference in serum insulin or glucose levels compared to controls [65]. However, 
it is speculated that lifelong treatment with immuno-suppressants for preventing 
rejection of the transplanted kidney protects these patients against the 
development of type I diabetes. 
5. Conventional KO mouse models in podocyte research 
Experimental rat models have been widely used in glomerular injury research. 
The advantages of rat models are that they have been carefully characterized 
during the past decades, can be performed in adult animals and allow collection 
of time-dependent tissue samples after disease induction. Most of these models 
are based on chemical or antibody induced glomerular failure. The disadvantages 
of these models are that their effect is systemic, their action site and mechanism 
are relatively poorly known, they have side effects in other tissues, their 
therapeutic window is narrow, and in different genetic strains the dose is difficult 
to estimate.  
After complete mapping of the genetic code and improvements in 
techniques for using ES cells, the number of different genetically modified mouse 
models has increased expotentially. The mouse is an excellent model to study 
human biology and disease, because of the similarities between genes and 
cellular functions in mammalian species. Conventional gene deletion in ES cells 
can be done by using homologous recombination or gene-trapping techniques as 
was previously described in the generation of nephrin deficient mouse-lines [5, 6]. 
The gene-trapping approach is based on random mutagenesis caused by random 
integration of a strong splice acceptor vector into the genome by using 
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endogenous splicing sites [77]. In homologous recombination a designed genetic 
vector is introduced into the specific genetic locus of mouse ES cells to cause a 
defined mutation [216]. Conventional gene KO mouse models of selected 
podocyte specific genes, their kidney phenotype and overall survival time are 
summarized in Table 2. 
 
Table 2. Conventional KO mouse-lines of selected podocyte-specific genes. 
 
Gene/ 
protein 
Gene 
locus 
Protein 
location 
KO 
Phenotype 
Kidney 
Phenotype 
Glomeruli 
Phenotype 
Efface-
ment 
Existing 
SDs 
Proteinuria 
started 
Life 
span 
Ref. 
Nphs1/ 
Nephrin 
19q13.1 SD Smaller Enlarged Fibrotic, 
hypercellular 
Yes No From birth 24h [5, 6] 
Neph1/ 
Neph1 
1q21-
25 
SD Smaller Normal Dilated 
juxtamedullary 
glomeruli 
Yes No From birth 3-8 
weeks 
[92] 
Nphs2/ 
Podocin 
1q25-
31 
SD Smaller Normal in 
size, 
hemorrhages 
Diffuse 
mesangial 
sclerosis  
Partial No From birth Few 
days 
[104] 
CD2AP/ 
CD2AP 
6p12 Near SD Smaller 
after 3w 
Normal Increase size 
and cellularity 
Partial Yes 2 w 6-7 
weeks 
[108] 
ACTN4/ 
α-act-4 
19q13 Podocyte Smaller 
after 6w  
Smaller Focal and 
segmental 
glomeruloscl. 
Partial Yes Mild > 10 
weeks 
[134] 
TRPC6/ 
TRPC6 
11q21-
22 
Podocyte Elevated 
blood 
pressure 
Not reported  Not reported Not 
reported 
Not 
reported 
Not reported Normal [141] 
Fyn/ 
Fyn 
6q21 SD Normal Normal Mesangial 
expansion 
and hypercell. 
Partial Mostly No 
proteinuria 
> 60 
weeks 
[144] 
Nck1/ 
Nck1 
3q21 Podocyte Normal Normal Normal No Yes No 
proteinuria 
Normal [159] 
Nck2/ 
Nck2 
2q12 Podocyte Normal Normal Normal No Yes No 
proteinuria 
Normal [159] 
 
6. Novel conditional genetic mouse models in targeted podocyte 
research  
Research into the role of the impaired glomerular filtration barrier and its specific 
components in mature kidney has been partly hampered by a lack of viable 
animal models because of early postinatal lethality (Table 2). To overcome this 
problem, new strategies are needed where transgenic gene expression is tightly 
regulated in a tissue and time specific manner during embryogenesis or in adult 
mice.  
6.1. Podocyte specific gene expression and promoters 
Expression of a gene of interest in a cell-specific manner is carried out by 
microinjection of a transgene expression cassette into the pronucleus of a 
developing zygote or oocyte resulting in random integration of the transgene into 
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the mouse genome [216, 217]. Transgene expression vectors contain two major 
components: the promoter driving transgene expression under spatial control and 
the transcription unit including the Kozak consensus sequence, coding exons and 
a termination signal (poly-A-tail) [216, 218, 219]. 
 
Table 3. Kidney-specific promoters. 
 
Promoter Renal expression Extra-renal 
expression 
Reference 
Nephrin Podocytes Brain [221] 
Podocin Podocytes None [222] 
Kidney androgen 
promoter 2 
Proximal tubules Brain [223] 
γ-Glutamyl 
transpeptidase 
Cortical tubules None [224] 
Na/glucose 
cotransporter  
Proximal tubules None [225] 
Aquaporin-2 Collecting ducts Testis, Vas 
deferens 
[226] 
Hox-B7 Collecting ducts, ureteric 
bud, Wolffian duct, ureter 
Spinal cord, 
dorsal root 
ganglia 
[227] 
Ksp-cadherin Renal tubules, collecting 
ducts, ureteric bud, Wolffian 
duct, mesonephros 
Müllerian duct [228, 229] 
Tamm-Horsfall 
protein 
Henle’s loop Testis, brain [230] 
Renin Juxtaglomerular cells, 
afferent artelioles 
Adrenal gland, 
testis, 
sympathetic 
ganglia 
[231, 232] 
 
Several kidney-specific promoters have now been characterized and are 
summarized in Table 3. By using these promoters, it is possible to determine 
whether cell-specific modification of candidate genes expression protects or leads 
to kidney disease. Interestingly, many of these kidney specific promoters drive 
expression also in the testis and CNS. Despite the growing list of kidney-specific 
promoters, only two promoters have been characterized that direct expression in 
the glomerulus and in the podocytes. A 1.25 kb fragment of the human nephrin 
promoter and 8.3 kb, 5.4 kb, 4.125 kb, and 1.25 kb fragments of the murine 
nephrin promoter direct expression in the podocytes and the CNS and pancreas 
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[67, 116, 220, 221]. A 2.5 kb fragment of the promoter from a second gene, 
podocin, directs expression only in podocytes without any noticeable influence on 
extra-renal tissues [222].  
6.2. Site-specific recombinases in the podocytes  
In addition to over-expression studies, the same promoters can be used to delete 
or down-regulate a gene in the selected cells by using site-specific recombinase 
systems. Two different recombinase systems have been used successfully in 
vivo; the Cre-loxP from the bacteriophage P1 [233] and the FLP-FRT from the 
budding yeast Saccharomyces cerevisiae [234, 235] (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Two different site-specific recombinase systems have been used successfully in vivo; 
the Cre-loxP from the bacteriophage P1 and the FLP-FRT from the budding yeast Saccharomyces 
cerevisiae.  A) Both recombinases Cre and FLP recognize a 34-bp consensus sequence known 
as loxP and FRT, respectively, and induce recombination between two of these sites. B) Cross-
breeding between a mouse-line containing a loxP/FRT flanked gene and a mouse-line expressing 
Cre/FLP recombinases under a tissue-specific promoter, results in littermates with selected genes 
deleted in a spatial manner. 
 
The Cre-loxP system has been most widely used in the generation of 
targeted gene deletion in the mouse. Cre recombinase is a 38 kDa protein that 
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recognizes a 34 bp DNA target called locus of X-over of P1 (loxP) and was 
discovered in the bacteriophage P1 [233]. When two loxP sites are located on the 
same DNA molecule, Cre causes inversion or excision of the intervening DNA 
segment depending on their respective orientation. Two transgenic mouse-lines 
are needed to perform tissue specific KO. The first mouse-line expresses Cre 
recombinase under the control of a tissue specific promoter. The second carries 
loxP sites around the gene of interest (floxed gene). Cross-breeding these two 
lines removes the selected gene in a tissue specific manner [236]. The Cre-loxP 
system can also be used to activate the over-expression of genes by excision of a 
"floxed STOP codon" placed between a highly active promoter and the gene of 
interest [237, 238].  
An alternative approach for the Cre-loxP system is the FLP-FRT system. 
FLP recombinase recognizes a 34 bp consensus sequence known as FLP 
recombination target (FRT) and induces recombination between two of these sites 
[234, 235]. The activities of Cre and FLP have different temperature sensitivities 
in vitro. Cre was shown to be active over a wider range of temperatures than FLP, 
with a maximal performance at 42°C and therefore offered a theoretical 
advantage for use in vivo [239]. To improve the activity of FLP, an FLP mutant 
was developed by introducing four amino acid changes (Flpe) [240]. FLPe has 
activity in ES cell cultures equivalent to that of Cre and thus should be just as 
useful for in vivo experiments. Combining both FLP and Cre systems may allow 
an investigator to target cell lineages that would otherwise be inaccessible. 
In the glomerular research field, only the Cre-loxP system has been used 
for targeted gene deletion in mice. Several different podocyte specific Cre mouse-
lines have been characterized. One is under the control of the 4.125 kb fragment 
of murine nephrin [220] and another one under the control of the 2.5 kb fragment 
of human podocin [241]. Recently expression of the nestin gene in podocytes was 
reported [242]. Nestin is also expressed in CNS, pancreas and heart [242-246]. 
Transgenic mice expressing Cre recombinase under the control of the rat nestin 
promoter are commercially available from Jackson Laboratories [244]. 
However, so far only a few conditional models using these Cre-lines in 
podocytes have been published. A nephrin-Cre mouse-line has been used to 
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study the role of vascular endothelial growth factor A deficiency in renal disease 
[247-249]. A podocin-Cre mouse-line has been used to study the role of intergrin 
linked kinase deletion [250, 251] and HIV-1 Nef over-expression in podocytes 
[252].  
6.3. Inducible systems 
In order to study the role of specific genes in the adult mouse or in various state of 
disease, a temporal control of gene expression in addition to tissue specificity is 
needed. To achieve this goal tetracycline-sensitive systems have been 
successfully employed in the kidney. The binary tetracycline-controlled 
transcriptional activation system is a powerful tool in achieving temporal control of 
transgene expression in mammals [253]. For this purpose, two different 
tetracycline-controlled activators are widely used in transgenic mice (Figure 6A). 
The original transcriptional activator (tTA) activates transcription of the 
target gene in the absence of tetracycline after binding to the tetracycine operator 
sequence (Tet-O) located in the 5' region of the target gene (Tet-off system) [254]. 
The reverse tetracycline-controlled transcriptional activator (rtTA) binds to Tet-O 
and activates transcription of the target gene in the presence of tetracycline (Tet-
on system) [253]. A major problem of Tet-on system is leakiness in uninduced 
animals [255, 256], but improved rtTA versions have been developed for avoiding 
this leakage. These constructs require far lower tetracycline concentration for the 
induction together with minimal background expression of Cre recombinase in the 
absence of tetracycline [257]. Furthermore the tetracycline-controlled 
transcriptional silencer (tTS) is a transcriptional repressor specially designed for 
use with the Tet-on system and prevents unregulated gene expression, when 
tetracycline is absent [256, 258, 259]. 
Mice carrying Tet-off or Tet-on transcriptional regulation can be bred with a 
mouse-line that contains Tet-O activator together with the cytolomegalovirus 
(CMV) minimal promoter driving Cre recombinase and a mouse-line with floxed 
genes of interest to achieve temporal and spatial gene deletion. Addition of 
tetracycline or its derivative doxycycline to the drinking water initiates the 
expression of Cre recombinase and deletes the targeted gene selectively in the 
preferred tissue. Although widely used in vivo, a disadvantage of the tetracycline 
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system is that to delete the gene of interest in a temporal manner the generation 
of triple-transgenic offspring is required (Figure 6B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Two different time-specific tetracycline inducible systems have been used successfully 
in vivo. A) The original transcriptional activator (tTA) activates transcription of the target gene in 
the absence of tetracycline after binding to the Tet operator sequence (Tet-O), located in the 5' 
region of the target gene (Tet-off system). The reverse tetracycline-controlled transcriptional 
activator (rtTA) binds to Tet-O and activates transcription of the target gene in the presence of 
tetracycline (Tet-on system). B) To knock-out the gene of interest in a temporal manner the 
generation of triple-transgenic offspring is required. The first mouse-line contains the tissue-
specific promoter to drive expression of the rtTA cassette. These mice can be bred with a mouse-
line that contains Tet-O activator together with the CMV minimal promoter driving Cre recombinase 
and a mouse-line with the floxed genes of interest. This generates offspring from which the 
selected gene can be deleted by tetracycline administration in a spatial and temporal manner.  
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“All-in-one” strategies have been developed to avoid the generation of 
triple-transgenic offspring. In this strategy, two expression units of the Tet-off 
system [260] or the Tet-on system [261, 262] on a single DNA fragment can be 
integrated in one cloning step. However, whether this “all-in-one” system is 
functional in transgenic mice remains to be fully elucidated. Another technique 
that overcomes this problem is the development of ligand-regulated forms of Cre 
recombinase by fusing a mutant estrogen receptor (ER) ligand-binding domain to 
the COOH terminal of enzymes. These fusion proteins are induced by the 
application of a synthetic estrogen antagonist 4-OH tamoxifen but are insensitive 
to endogenous ß-estradiol. Three different mutant estrogen receptors have been 
reported: mouse ERTM [263], human ERT [264] and human ERT2 [265]. CreERT2 
has been reported to be 10 times more sensitive than CreERT [266]. 
Inducible gene deletion has been used in mouse for many targets including 
the liver [267, 268], heart [269, 270], kidney collecting ducts cells [271] and 
prostaglandin receptors [272]. In kidney glomeruli research, several inducible 
mouse-lines have been characterized. The first tetracycline inducible transgenic-
line consisted of the podocin promoter to drive expression of the rtTA cassette in 
podocytes. The limitation of this mouse-line, is that the generation of triple-
transgenic offspring is required [273]. Previously, a tamoxifen inducible mouse-
line has been generated that expresses Cre recombinase in podocytes but also in 
a variety of other tissues including striated/smooth muscles, some pancreatic 
cells, and cultured primary fibroblasts derived from the ear [274]. This mouse-line 
was used successfully to over-express the Pax2 transcription factor in adult mice 
and to reveal its role in the development of glomerular diseases in mature 
podocytes [178]. The CreERT2 system has also  been used  in renal epithelial 
cells under the control of the Ksp-cadherin promoter [275]. However, there is still 
a great need to generate simpler and faster systems to delete selected genes only 
in the podocytes in a temporally controlled manner without extensive breeding 
steps and gene deletion in other tissues.  
6.4. RNA Interference 
Although mouse mutants lacking a specific gene are often useful for analyzing 
gene function, the traditional procedure used to generate mutant mice by 
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homologous recombination in ES cells is costly and time-consuming. RNAi 
technique provides an alternative approach by inducing sequence-specific mRNA 
degradation [276]. RNAi is a highly conserved mechanism throughout evolution 
and can be found from plants to humans. RNAi is the process of sequence-
specific, post-transcriptional gene silencing initiated by double-stranded (dsRNA) 
that is homologous in sequence to the silenced gene. The presence of dsRNA in 
the cytoplasm activates Dicer enzymes that cleave the RNA into short pieces 
[276]. The mediators of sequence specific mRNA degradation are 21 and 22-
nucleotide small interfering RNAs (siRNAs) [277]. These siRNAs are incorporated 
into a multiprotein RNA-inducing silencing complex (RISC). The antisense strand 
guides RISC to its homologous target mRNA resulting in cleavage. 
Chemically synthetized siRNA has been used succesfully for mRNA 
degradation in mammalian cultured cells. However, despite its downregulation 
efficiency, the effect is only transient and can not be used effectively for gene 
silencing in vivo [277, 278]. To overcome these problems, techniques have been 
developed using DNA-vectors that can integrate into the host genome and 
express substrates in a stable manner, which can be further converted into 
siRNAs in vivo [279-281]. The RNA Pol III H1- and U6-RNA gene promoters were 
shown to efficiently produce RNA from a DNA template in cultured cells [280]. 
Meanwhile, it has been shown that Dicer can process short (shRNA) or long 
hairpin dsRNA structures resulting in the generation of appropriate siRNAs [281]. 
Produced siRNA can then effectively silence target mRNA expression making it 
possible to downregulate genes by using only one vector that produce the hairpin 
structure [279-281]. Some of these constructs can silence gene expression in a 
stable manner in transgenic mice [281].  
However, the Pol III promoter is active in all tissues and the use of the RNA 
Pol II promoter is essential for developing a method to efficiently generate partly 
tissue-specific knockdown mice. One of the difficulties using a long dsRNA 
transcribed from the Pol II promoter is the interferon response [282]. In mammals, 
the introduction of long dsRNAs into the cells leads to an inhibitory response 
mediated through release and synthesis de novo of interferon similar to a viral 
infection. This leads to a block in translation and sequence-nonspecific mRNA 
degradation [278]. Pol II transcripts are transferred to the cytosol immediately after 
 
 
56
transcription, where they induce interferon synthesis [282]. To prevent the 
interferon response, the pDECAP (DEletion of CAP structure and poly(A)) vector 
which express a long ds-RNA regulated by the Pol II promoter has been used 
[281]. This efficiently blocks the export of long dsRNA to the cytosol [281]. The 
pDECAP transcript lacks both the 5´-cap structure and the 3´-polyA tail which 
prevents export of dsRNA to the cytosol and non-specific mRNA degraration 
caused by interferon response [281]. Because the ribonuclease(s) such as Dicer 
which cleave long ds-RNA are localized in both the nucleus and the cytoplasm 
[283], the long dsRNA expressed by this vector is expected to be processed into 
siRNA already in the nucleus. siRNA then moves to the cytosol and induce the 
degradation of target mRNA [273]. In the future, spatial and temporal control of 
dsRNA expression in the kidney should be possible by using a combination of 
inducible Cre mouse-lines, permitting rapid and high throughput analysis of gene 
function in a time and cost effective manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
57
Aims of this thesis 
The generation and analysis of various genetically modified mouse models were 
used to assess the biological function of nephrin. Specifically the aims of this 
thesis were: 
i) To generate novel podocyte-specific constructs that provides an inducible tool 
for in vitro and in vivo gene targeting. 
ii) To generate a podocyte-specific inducible Cre recombinase mouse-line that 
allows conditional and targeted gene deletion in adult mouse kidneys. 
iii) To study biological roles of nephrin in podocytes and in extra-renal tissues 
using nephrin KO mice rescued by podocyte-specific trasgenic rat nephrin 
expression. 
iv) To study the role of SD components in the testis. 
v) To generate a construct, with a long hairpin structure of dsRNA that allows 
stable densin and filtrin gene silencing in vitro and in vivo. 
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Materials and methods 
1. Human and mouse testis and brain samples (III)  
Frozen human testis samples were obtained from two adult patients who 
underwent prostate cancer surgery at the University of Helsinki (Department of 
Obstetrics and Gynecology). A frozen sample of normal brain tissue adjacent to a 
tumor in the temporal lobe was taken from a young adult during tumor surgery at 
the University of Helsinki (Department of Neurosurgery). The use of these human 
samples was approved by the local ethics committee and informed consent was 
obtained from the patients. 
Mouse testis samples were obtained from adult (20 weeks old, total body 
weight approximately 25 g) male C57BL/6 mice. After cervical dislocation, mouse 
testes were immediately dissected and snap frozen in liquid nitrogen and stored 
at -80°C until use. Brain tissues were dissected to serve as positive controls for 
densin expression. All animal experiments had the approval of the local 
committee for laboratory animal welfare of the University of Helsinki. 
2. Constructs and cloning 
2.1. Doxycycline inducible Cre recombinase construct (I) 
The p2.5PodocinpnlacF plasmid containing 2.5 kb of the genomic sequence of the 
human podocin promoter located 5' to the translation initiation codon was kindly 
provided by Dr. Lawrence Holzman [222, 241]. The “Core” construct was provided 
by W.H. Lee [262]. An EcoRI-HindIII fragment from the original rtTA of the core 
construct was replaced with the optimized version, rtTA-M2 [257]. However, 
several attempts to clone promoters into the designated cloning site failed due to 
the instability of the construct. Therefore the two functional EcoRI-ScaI fragments 
from the Core construct were reconstituted in a pBR322 based low copy 
backbone after modification of the polylinker, generating NotI restriction sites 
instead of ScaI on both sides of the transgene. Finally unique SalI and SmiI sites 
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were introduced at the position of the EcoRI site. The resulting construct was 
stable and designated as RRC-M2. 
The unique XbaI site in p2.5PodocinpnlacF was replaced by a SalI using a 
linker (sense: 5’-ctagcagatctaagcagtcgaca-3’ and antisense: 5’-
ctagtgtcgactgcttagatctg -3’). The resulting SalI-NcoI fragment of the podocin 
promoter was cloned into the SalI-SmiI digested RRC-M2 construct as a SalI-
blunt fragment. The NcoI end was blunted using T4 polymerase (New England 
Biolabs). The identity of the clones was verified by restriction mapping and 
sequencing. The final construct was designated JRC-CRE (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Different steps for cloning JRC-CRE and JRC-Nephrin constructs. 
2.2. Doxycycline inducible rat nephrin construct (II) 
The original RRC-M2 plasmid was digested by XhoI-NotI digestion and this 2.5 kb 
fragment was subcloned to the pBRGEM11 plasmid. A linker (sense: 5’-
ctagcagatctaagcagtcgaca-3’ and antisense: 5’-ctagtgtcgactgcttagatctg -3’) 
containing a SmiI site was cloned into the pBRGEM11 plasmid opened by SacII 
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digestion. In parallel, a linker (sense: 5’-ctagcagatctaagcagtcgaca-3’ and 
antisense: 5’-ctagtgtcgactgcttagatctg -3’) containing an additional SmiI restriction 
site was cloned into the SpeI site of the pBKCMVneph plasmid, containing 3.7 kb 
of the sequence of rat nephrin complementary DNA (cDNA). The polyA tail (pA) 
was cloned to the 3' end of the rat nephrin cDNA by ScaI-NotI digestions. 
Subsequently the construct was cut with SmiI-NotI and the resulting 4.3 kb 
fragment containing both rat nephrin cDNA and pA was cloned into the SmiI-NotI 
sites of the RRC-M2 vector. From the pGEM-T-Easy (Promega) vector containing 
572 bp of the sequence of the β-globin intron amplified by polymerase chain 
reaction (PCR) was released by EcoRI digestion. The cut fragment was blunted 
using T4 polymerase. The resulting blunted fragment of the β-globin intron was 
cloned into the SmiI site of the RRC-M2 vector containing rat nephrin cDNA and 
pA. 
Finally, the SalI-NotI fragment containing TetO-CMV-B-globin-rat nephrin-
pA sequence was cloned into the XhoI-NotI sites of the JRC-CRE construct 
containing the podocin promoter. The final construct was designated JRC-Nephrin 
(Figure 7). 
2.3. Long hairpin RNAi construct (Unpublished data) 
For RNAi contructs cloning, a recently published and academically free pDECAP 
vector donated by Dr. Ishii was used [281]. The DNA from three different 
fragments of the densin gene and two different fragments of the filtrin gene were 
cloned to p-DECAP vector followed by inverted repeats; 3´-sense 500 bp 5´-
spacer 12 bp - 5´-antisense 500 bp-3´. 
The constructs were transformed to SURE® 2 supercompetent cells 
(Stratagene). These cells have been engineered to allow the cloning of certain 
DNA segments, which are difficult to clone in conventional E. coli strains. The 
SURE strain lacks components of the pathways that catalyze the rearrangement 
and deletion of non-standard secondary and tertiary structures, including 
cruciform (caused by inverted repeats) and Z-DNA, which occur frequently in 
eukaryotic DNA and impede the cloning of eukaryotic DNA in conventional 
strains. 
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3. In vitro assays and micro-injection (I, II, Unpublished data) 
For in vitro testing of the constructs, the human embryonic kidney cell-line A293 
(American Type Culture Collection) was cultured in RPMI-1640 medium (Gibco 
Biocult) containing 10% fetal calf serum, penicillin (100 U/ml; NordCell) and 
streptomycin (100 µg/ml; NordCell). The cells were grown in 24-well plates to 70% 
confluency. Transfections were performed by Fugene 6 reagent™ (Roche 
Molecular Biochemicals) according to the manufacturer’s protocol.  
The JRC-CRE or JRC-Nephrin constructs were co-transfected with the 
pCAG20-1 vector containing a β-actin promoter to drive tTA2, as no podocin 
promoter activity was detected in A293 cells. Transfected cells were cultured for 
24 hours in the presence or absence of 2.0 μg/ml doxycycline hyclate (Sigma-
Aldrich). The cells transgenic mRNA and protein expression were analyzed using 
assays that are later described in this section. 
Tested constructs were purified by digestion of the plasmid and 
subsequent gel electrophoresis followed by DNA extraction using the QIAEX II 
Gel Extraction Kit (Qiagen). The purified construct DNA was introduced into the 
pronuclei of fertilized oocytes from FVB/N mice by microinjection using standard 
procedures. The resulting founders were identified by PCR on tail genomic DNA 
(50 to 100 ng), using different primer sets and 35 cycles at 95°C (30 s), 54°C (30 
s), and 72°C (30 s), and a final extension at 72°C for 5 min. The reaction was 
performed with HotStar Taq DNase polymerase (Qiagen) in a total volume of 20 
μl, including 400 nM of both primers. Samples were analyzed by standard 
agarose gel electrophoresis (1.5% gel).  
The RNAi constructs (250 ng of DNA), reporter vector (psiCHECK-1; 
Promega; 250 ng of DNA) and control plasmid (pGLBasic/SV40P; Promega; 100 
ng of DNA) were co-transfected to A293 cells using Fugene reagent™. The RNAi 
Renilla luciferase reporter vector psiCHECK-1 was modified by placing a mouse 
densin or filtrin full-length cDNA to the front of the luciferase gene. The silencing 
efficacies of the used RNAi constructs to Renilla luciferase activity were measured 
and normalized by using the co-transfected plasmid pGLBasic/SV40P as a control 
with Firefly luciferase. After transfection (24-48 hrs), the cells were assayed for 
luciferase activity with Dual-Luciferase Reporter Assay System (Promega) and 
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measured with a luminometer (Thermo Scientific). The results are presented as 
relative light units (RLU). 
4. Cross-breedings 
4.1. JRC-CRE x Z/AP reporter-line (I) 
To analyze transgenic Cre recombinase localization and activity, JRC-CRE 
transgenic founders were bred with lacZ/human placental alkaline phoshatase 
(Z/AP) reporter mice [284]. The Z/AP reporter mouse-line carries a ß-geo cassette 
flanked by two loxP sites and an alkaline phosphatase gene [284]. Alkaline 
phosphatase (AP) cannot be expressed in this transgene unless the ß-geo 
cassette is excised. Thus, these mice express AP after Cre-mediated 
recombination. Double transgenic mice were identified by PCR on tail genomic 
DNA. Offspring carrying both transgenes (JRC-Cre x Z/AP) were administrated 
0.2 mg/ml doxycycline in their drinking water for 14 consecutive days. 
4.2. Transgenic JRC-Nephrin x Nephrin KO mice (II) 
Mice from selected JRC-Nephrin founder-lines were cross-bred with nephrin 
deficient heterozygous mice [6]. The F1 offspring were intercrossed to generate 
F2 offspring that lack a functional endogenous nephrin gene while containing the 
inducible podocyte-specific rat nephrin transgene. Transgenic mice were 
identified by PCR on tail genomic DNA as described earlier [6]. The classification 
for the different genotypes was as follows: 1) JRC-Nephrin x wild-type control 
(Nephrin/WT/WT), 2) JRC-Nephrin x heterozygous KO (Nephrin/WT/KO) and 3) 
JRC-Nephrin x homozygous KO (Nephrin/KO/KO) mice. Doxycycline was 
administered to the F1 females via drinking water (2.0 mg/ml in 5% sucrose) from 
conception on and during pregnancy. After birth, doxycycline administration was 
continued via drinking water (2.0 mg/ml in 5% sucrose) for one to six weeks.  
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5. Phenotypic and histological characterization  
5.1. Determination of urinary protein level (II) 
Spot urine samples were collected from at least five mice of each genotype. The 
urinary protein levels were semiquantified with the Uristix (Bayer) protein assay as 
indicated on the Uristix test strip package.  
5.2. Determination of blood glucose level (II) 
Blood samples from mice were collected from at least three individual mice of 
each genotype. Glucose levels were quantified with the Accutrend Sensor (Roche 
Diagnostic Corporation) system by using Accu-Chek test-strips (Roche) according 
the manufacturer’s protocol.  
5.3. Primary behavioral screening (I and II) 
Ten-weeks-old JRC-CRE and five-weeks-old JRC-Nephrin x KO male mice from 
different genotypes was used for behavioral characterization. The employed 
battery of behavioral observational tests was a modification of the Irwin procedure 
[285], during which a total of 40 separate measurements were performed for each 
animal (for a full method description, See Shirpa Protocol): 
http://www.mgu.har.mrc.ac.uk/facilities/mutagenesis/mutabase . 
5.4. Histological characterization (II) 
The dissected tissues from one- and six-weeks-old JRC-Nephrin x KO mice of 
each genotype were fixed in 4% formaldehyde and embedded in paraffin. Two to 
three micrometer thick sections were cut, deparaffinized and stained with 
hematoxylin-eosin using standard procedures. The slides were observed with an 
Olympus Provis microscope. 
For electron microscopic examination, kidney cortex samples from one and 
six-weeks-old JRC-Nephrin x KO mice were fixed in 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4) at room temperature for two hours. The samples were 
postfixed in 1% osmium tetroxide (OsO4) in the same buffer for one hour and 
stained en-bloc in 1% uranyl acetate in 10% ethanol for one hour, after which they 
were dehydrated in ethanol and embedded in LX112. Semithin sections were 
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stained with toluidine blue. Thin sections were stained with uranyl acetate and 
lead citrate and examined with a Jeol JEM 1200EX electron microscope. 
6. mRNA expression (I, II, III) 
mRNA expression was measured using the reverse transcription (RT)-PCR 
method. After cervical dislocation, mouse tissues were dissected immediately, 
snap frozen in liquid nitrogen and stored at -80°C until use. Total RNA was 
extracted from homogenized lysate of frozen samples using the RNeasy Mini Kit 
(Qiagen) according to the manufacture’s instructions. cDNA was prepared from 1 
µg RNA with the M-MLV reverse transcriptase (Promega) using random primers 
(Roche) (RT+). To confirm the RNA origin of the PCR signals each sample was 
also analysed without the reverse transcription reaction (RT-). Tissue cDNA was 
amplified by PCR using the primers presented in Table 4. The PCR reaction was 
carried out as described above with 35-40 cycles. 
 
Table 4. Oligonucleotide primers used in RT-PCR:s. 
 
Copied cDNA Forward Primer 5’ -3’  Reverse Primer 5’ -3’ Size of 
Product 
Used 
in 
study:
Cre recombinase gaccaggttcgttcactca tagcgccgtaaatcaat 420 bp I 
Nephrin cctggagctaccctgcata ggacttggtaaggcagcaaa 317 bp I 
Rat Nephrin  caggtacagcctggaaggagatc tcctctgatccctcattcacat 335 bp II 
Mouse Nephrin aggtacagcctggaaggagaca tcctctgatccctcattcacgc 335 bp II 
Podocin ccagcttcgatacttgcaca ctttgcccattcgcctataa 210 bp II 
Synaptopodin gctgctggagcactgggc ttggagagcctggctttg 298 bp II 
CD2AP gttgggactgtttccctcaa tttctttggctgtgcaactg 172 bp II 
FAT1 gtgacggacgttgaggaaat actgctgttctgtggtgtcg 182 bp II 
Fyn cgaactacaacttccac ctggagccacgtaattgctg 279 bp II 
Nck1 aaggacaccttaggtattgg agagaacctacatgatcacc 311 bp II 
Nck2 gaacctcaaggacacactag cgtaggctcaggaagctggg 342 bp II 
Beta-actin ttccttcttgggtatggaat ggccaggatggagccaccga 250 bp II 
Densin atgctttccctgacaactgg gtgtgtctgtgggtggactg 208 bp III 
Beta-actin aaccgcgagaagatgacccagatcatgttt agcagccgtggccatctccttgctcgaagtc 351 bp III 
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7. Protein expression 
7.1. Immunoblotting (I, II, III) 
Samples of frozen tissues were lysed on ice with a glassware homogenizer in 
RIPA lysis buffer (150 mmol l-1 NaCl, 1% NP40, 0.5% deoxycholic acid, 0.1% 
sodium dodecyl sulfate [SDS], 50 mmol l-1 Trizma base [pH 8], 0.02% NaN3) with 
a protease inhibitor mixture (Complete Mini, EDTA-free, Roche Diagnostics), 
centrifuged (5 min at 14000g), and the protein concentration of the supernatant 
was measured with the BCA Protein Assay Kit (Pierce). Samples were boiled for 5 
min at 100°C in reducing 1 x LSB-buffer (4 x LSB: 125 mmol l-1 Tris-HCl [pH 6.8] 
20% glycerol, 0.04% SDS, 10% 2-mercaptoethanol, 0.001% bromophenol blue). 
The proteins were resolved by SDS-polyacrylamide gel electrophoresis on 10% 
gels and were transferred to nitrocellulose membranes (Amersham Biosciences). 
Membranes were blocked with 3% bovine serum albumin (BSA), 0.05% Tween-20 
in PBS at 4°C overnight or with Odyssey reagent (LI-COR) 1h at RT. The 
membranes were incubated with the same antibodies as used in the 
immunofluorescence staining at 4°C overnight. The membranes were then 
incubated either with affinity-purified peroxidase-conjugated goat anti-rabbit IgG 
(Jackson Immuno Research Laboratories; 1:50000) or with goat anti-mouse or 
anti-rabbit secondary antibodies conjugated to AlexaFluor 680 (Molecular Probes; 
1:10000) or IRdye 800 (Rockland Immunochemicals; 1:10000). The Supersignal 
West Pico Chemiluminescent Substrate (Pierce) or the Odyssey infrared imaging 
system (LI-COR) was used to detect the bound antibodies. 
7.2. Immunofluorescence staining (I,II,III) 
Immunofluorescence staining for selected antibodies was performed on frozen 
mouse sections (6 μm). The sections were air-dried, fixed with acetone (–20°C) 
for 2-10 min, washed with PBS and blocked with CAS Block solution (Zymed 
Laboratories Inc.) for 10 min. The sections were incubated at 4°C overnight with 
the primary antibody in ChemMate Antibody Diluent (DakoCytomation). After 
washing, the sections were incubated with affinity-purified TRITC-conjugated goat 
anti-rabbit IgG (1:200; Jackson Laboratories) and/or affinity-purified FITC-
conjugated goat anti-mouse (Jackson ImmunoResearch Laboratories; 1:200) in 
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PBS for 30 minutes, mounted with Vectashield Mounting Medium for fluorescence 
with 4’,6-diamidino-2-phenylindole (DAPI; Vector Laboratories). The slides were 
observed with an Olympus Provis microscope equipped with filters to detect 
fluorescence.  
7.3. Alkaline phosphatase substrate staining (I) 
For testing the presence of AP, the JRC-CRE x Z/AP and WT control mice either 
received (n=3) or did not receive doxycycline (n=3). A list of the tissues collected 
is provided in the original publication I (Table 2). 
Prior to staining slides were re-fixed in cold PBS containing 0.2% 
glutaraldehyde for 10 min. After fixation the slides were washed in PBS for 5 min 
and endogenous AP was inactivated by incubating the slides in PBS at 75°C for 
30 min. The slides were rinsed with PBS, washed in AP buffer (100 mM Tris–HCl, 
[pH 9.5], 100 mM NaCl, 10 mM MgCl2) for 5 min, followed by incubation with BM 
purple (Roche) for 1 hr at 4°C to detect AP activity. Gurr Aquamount (BDH) was 
used for mounting. The slides were observed with an Olympus Provis microscope. 
8. Statistical analyses (I, II, III) 
The results are presented as means ± standard deviation. Statistical analyses 
were carried out using SPSS for Windows 12.01 (SPSS Inc.). Analyses were 
performed using a one-way analysis of variance. When statistically significant 
differences (P < 0.05) were found, post-hoc comparisons were carried out using 
the least significant difference test (LSD). 
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Results  
1. A novel inducible mouse-line for podocyte-specific gene 
deletion (I) 
In order to generate a mouse-line with doxycycline inducible Cre recombinase 
expression only in podocytes, a Tet-on construct with podocin promoter called 
JRC-CRE was cloned as detailed in materials and methods (Orig. I, Fig. 1). Prior 
to pronuclear injection, the inducible construct was tested in vitro in A293 cell 
culture. Cre recombinase expression was localized within the nuclei and was 
tightly regulated by doxycycline administration. The construct was injected into 
FVB/N mouse oocytes and 16 out of 122 offspring were found to carry the 
transgene. To achieve an inducible mouse-line in which transgene is transferred 
to F1 littermates, these founders were back-crossed with C57Bl/6 WT mice. All 
founders were fertile and transmitted the transgene to their F1 offspring. The 
phenotype of F1 littermates was normal and remained normal after a two-week 
administration period of 0.2 mg/ml doxycycline compared to WT controls. 
1.1. Doxycycline dependent expression of Cre recombinase in the adult 
mouse  
To prove time- and tissue-specific Cre recombinase mRNA expression in the adult 
mouse kidneys, F1 offsprings at the age of eight to ten weeks were treated with 
doxycycline, and mRNA expressions were analyzed by RT-PCR. These results 
showed that expression of Cre recombinase mRNA was observed only in the 
kidney cortex and only after doxycycline treatment (Orig. I, Fig. 2). 
To determine the specific localization of Cre recombinase protein 
expression in the kidney cortex, renal cryosections from F1 littermates were 
examined by Cre antibody immunofluorescence staining before or after 
doxycycline treatment. These studies indicated that expression of Cre 
recombinase was prominent in the periphery of the glomeruli, which is consistent 
with the localization of the podocytes. Cre recombinase protein expression was 
absent in the WT and in the JRC-CRE controls not treated with doxycycline (Orig. 
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I, Fig. 3). Cre recombinase protein expression was not observed in the other 
tissues analyzed including heart, liver and pancreas (Orig. I, Fig. 4). 
1.2. Functionality of inducible Cre recombinase in podocytes 
To test Cre recombinase capability to catalyze recombination between two loxP 
sites, cross-breeding with a Z/AP reporter mouse-line was performed. Cre 
recombinase expression excises the ß-geo cassette from reporter mouse-line 
genomics and induces AP expression. This was tested in a set of tissues from all 
founder-lines by using AP substrate staining. Three founder-lines out of sixteen 
showed Cre recombinase expression in podocytes without doxycycline 
administration. Two founder-lines out of sixteen expressed Cre recombinase in 
heart tissue after two weeks of doxycycline administration. For further studies one 
founder-line was selected because it had a high Cre recombinase expression 
level only in podocytes, and inaddition it lacked leakiness without doxycycline 
administration.  
1.3. Localization of Cre recombinase expression in podocytes 
To determine the localization of human placental AP protein expression as a 
marker for Cre activity, the kidney tissues of reporter mice were examined by 
immunofluorescence microscopy with antibodies against AP, synaptopodin and 
WT1. Double stainings showed that expression of AP co-localized with 
synaptopodin protein, but not with WT1 podocyte-specific nuclear staining. A total 
of one hundred glomeruli from several sections were counted. All glomeruli 
positive for synaptopodin also showed high expression for AP in doxycycline 
treated double transgenic mice. AP protein expression was not observed in 
double transgenic mice without doxycycline or in WT controls (Orig. I, Fig. 5). 
Nevertheless it might be that all podocytes do not express Cre recombinase upon 
induction, but the present data suggest that the percentage is very substantial. 
2. A novel inducible mouse-line for podocyte-specific nephrin 
over-expression (II) 
To evaluate the role of transgenic over-expression in adult mouse kidneys, a 
podocyte-specific inducible rat nephrin mouse-line was generated. The construct 
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expressing doxycycline inducible rat nephrin (Orig. II, Fig. 1) under the control of 
podocin promoter was cloned and tested in an A293 cell-line, which showed no 
endogenous nephrin expression. The introduced rat nephrin expression was 
tightly regulated by doxycycline administration and was localized preferentially in 
the cell membrane and in the developing cell protrusions (Figure 8). Similar 
findings have also been reported with the rat nephrin transgene and HEK293T 
cells. On the basis of those results, it was suggested that morphological changes 
including cell protrusions and spikes, are mediated by nephrin tyrosine 
phosphorylation and by Nck interaction [148] . 
 
Figure 8.  Inducible rat nephrin expression in A293 cells. A293 cells were co-transfected with the 
JRC-Nephrin construct and pCAG20-1 construct containing the β-actin promoter driving the tTA2 
expression. Doxycycline (2 μg/ml) was added to the wells 24 h before fixation of the cells to shut-
down nephrin expression. A, B) Doxycycline 2 μg/ml treated co-transfected A293 cells do not 
show any nephrin staining. C, D) Nephrin expression in co-transfected A293 cells without 
doxycycline treatment. Magnification: x100 (A and C) and x200 (B and D). 
 
After in vitro testing the construct was injected into FVB/N mouse oocytes, 
which resulted in 10 out of 90 pups carrying the transgene as detected by PCR. In 
order to achieve a mouse-line with doxycycline inducible rat nephrin expression 
only in podocytes, these founders were cross-bred with C57Bl and ICR WT mice. 
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Eight out of 10 founders transmitted the transgene to their offspring (F1). All 
founders and their F1 offspring were fertile and their tissue phenotypes were 
normal. After a two-week administration period of 0.2 mg/ml doxycycline, the 
phenotype of these F1 offspring remained healthy with normal body weight as 
noticed in WT controls.  
2.1. Doxycycline regulated expression of rat nephrin in podocytes  
Nephrin mRNA expression was studied in the kidney cortex of F1 adults carrying 
the transgene at the age of 10 to 12 weeks by RT-PCR. Expression of rat nephrin 
mRNA was observed in F1 offspring from five out of seven founder-lines. The 
expression was firmly regulated by the administration of doxycycline and 
observed only in the kidney cortex (Orig. II, Fig. 1). Transgenic rat nephrin 
expression was not found in other extra-renal tissues obtained from F1 
littermates, which included testis, cerebellum, cortex, pancreas, heart, liver and 
ovaries. Doxycycline induced expression of the rat nephrin showed similar 
expression pattern as endogenous nephrin and was localized only in the 
podocytes. The expression of transgenic rat nephrin did neither alter the 
expression of the other podocyte-specific genes or their protein localization. 
3. Inducible nephrin transgene expression in podocytes rescues 
nephrin deficient mice from perinatal death (II and unpublished 
data) 
Conventional nephrin KO in mice leads to early lethal phenotype [6]. In order to 
investigate whether inducible transgene expression of rat nephrin only in 
podocytes can rescue nephrin KO mice from perinatal lethality, a podocyte-
specific rat nephrin mouse-line was crossed with nephrin KO mouse-line. Cross-
breedings in the presence of doxycycline resulted in an F2 generation of 72 pups 
of which 14 (10 males and four females) carried the rat nephrin transgene and 
were homozygous for the KO allele lacking endogenous nephrin expression 
(Nephrin/KO/KO) as verified by PCR. Three offspring were sacrificed at the age of 
one week. Two female pups died at the age of seven to 14 days. Three males 
died at the age of 38 and 40 days and showed severe proteinuria (> 3.0 g/l) with 
 
 
71
histological changes in the kidney morphology that included glomerular changes 
and tubular dilatations with proteinaceous material. Five males and one female 
survived until the age of six weeks and were sacrificed for further analysis.  
3.1. Impaired locomotor activity in Nephrin/KO/KO mice  
Deficiency of endogenous nephrin was associated with significant impairments in 
locomotor activity in comparison with other genotypes as summarized in Table 5. 
Behavioral evaluation in the viewing jar showed decreased spontaneous activity 
in Nephrin/KO/KO mice compared to other genotypes (P < 0.05). In an open 
arena, elevated pelvic and tail dragging during locomotion was observed in all 
Nephrin/KO/KO mice (P < 0.001). Nephrin/KO/KO mice had also reduced 
locomotor activity in the novel environment (P < 0.05). No statistically significant 
behavioural differences between Nephrin/WT/WT and Nephrin/WT/KO genotypes 
were found. 
 
Table 5. Differences between JRC-Nephrin x Nephrin KO mice in the primary 
behavioral screening. 
 
Mean ± S.D. or number of mice exhibiting of the observed behavior 
  Nephrin/WT/WT Nephrin/WT/KO Nephrin/KO/KO 
       n=3       n=3       n=5 
Spontaneous Activity 2.33 ± 0.57 2.67 ± 0.58 1.20 ± 0.45 * 
Locomotor Activity 24,67 ± 6.43 23.67 ± 7.57 11.80 ± 5.45 * 
Elevated Pelvic  0 0 5*** 
Dragging Tail 0 0 5*** 
 
Statistically significant differences after LSD test: * P < 0.05; ***P < 0.001. 
 
3.2. Podocyte specific rescue of nephrin results in severe tissue 
phenotypes 
All Nephrin/KO/KO mice that survived for six weeks were notably sick, smaller in 
size and had significantly lower body weights (Figure 9 A and B). They all suffered 
from severe proteinuria at the age of three weeks (> 3.0 g/l). Blood glucose levels 
were decreased dramatically in Nephrin/KO/KO littermates (P < 0.001) and were 
also decreased in Nephrin/WT/KO (P < 0.05) compared to Nephrin/WT/WT 
controls (Table 6). The tissue/body weight ratios of kidneys, brain, heart and 
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testicles were increased in Nephrin/KO/KO littermates compared to other 
genotypes, which may be due to the smaller body weight (Table 6).  
 
Table 6. Phenotypic parameters measured from six-weeks-old JRC-Nephrin x 
Nephrin KO mice. 
     
Average Tissue Weight Compared to 
Body Weight (%) 
Geno-
type n 
Body 
Weight 
(g) 
Protein 
in 
Urine 
(g/l) 
Glucose 
in 
Blood 
(mmol/l) Kidney Brain Heart Testis Spleen
Nephrin/ 
WT/WT 3 
25.4 ± 
5.3 0.3-1.0 
13.2 ± 
1.6 
2.24 ± 
0.14 
1.97 ± 
0.11 
0.66 ± 
0.13 
0.79 ± 
0.12 
0.50 ± 
0.12 
Nephrin/ 
WT/KO 3 
25.7 ± 
4.8 0.3-1.0 
10.3± 
1.2* 
2.15 ± 
0.07 
1.86 ± 
0.21 
0.67 ± 
0.03 
0.81 ± 
0.11 
0.63 ± 
0.07 
Nephrin/ 
KO/KO 3 
15.2 ± 
6.4*** ≥ 3 
5.0 ± 
1.7*** 
2.56 ± 
0.11* 
4.02 ± 
0.30***
1.01 ± 
0.23* 
1.31 ± 
0.34* 
0.46 ± 
0.30 
 
Statistical significant differences after LSD test compared Nephrin/WT/WT group: 
* P < 0.05; *** P < 0.001. 
 
Glomerular morphology of the Nephrin/WT/WT mice was normal at both 
one and six weeks of age as analyzed by light microscope after hematoxyllin-
eosin staining. The kidneys of one-week-old Nephrin/KO/KO mice didn’t show any 
major morphological differences compared to Nephrin/WT/WT littermates. 
However, the kidneys of six-weeks-old Nephrin/KO/KO mice showed striking 
morphological differences compared to age matched Nephrin/WT/WT littermates. 
The abnormalities in the kidney include a remarkable increase in glomerular 
extracellular matrix and sclerosis, abundance of partly collapsed glomeruli 
together with cystic lesions filled with proteinaceous material and tubular 
dilatations (Orig. II, Fig. 2).  
In electron microscopy analysis, varying levels of podocyte damage was 
seen in both the one-week-old and six-weeks-old Nephrin/KO/KO mice (Orig. II, 
Fig. 3). This is in contrast to the Nephrin/WT/WT littermate controls that showed 
normal podocyte structure. Podocyte abnormalities seen in the Nephrin/KO/KO 
mice in both ages, usually consisted of a distinct loss or fusion of foot processes. 
The six-weeks-old Nephrin/KO/KO mice glomeruli also showed 
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glomerulosclerosis, mesangial expansion and glomerular basement membrane 
thickening. SDs were still partly existing in Nephrin/KO/KO mice in both analyzed 
ages despite the foot process effacement, although these were completely 
missing in conventional nephrin KO newborns [6].  
 
Figure 9. Endogenous nephrin deficiency causes genital track malformations in Nephrin/KO/KO 
mouse: Left panel: Nephrin/WT/WT mouse; Right panel: Nephrin/KO/KO mouse. Panels A and B 
show the differences in body size; Panels C and D show the smaller size of the male genitals of 
Nephrin/KO/KO males and undeveloped scrotum; Panels E and F show the abnormalities in the 
male reproductive tract development in Nephrin KO/KO mice. Testicles of these mice were not 
descended and the formation of seminal vesicle and prostate were impaired. 
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All Nephrin/KO/KO males were infertile and their genitals showed 
anatomical and developmental malformations. Notably, their penis size was 
decreased, testicles had not descended and seminal vesicle formation was 
severely impaired (Figure 9 C to F). Histological changes were analyzed from 
sites of previously reported nephrin expression. The qualitative changes found 
included, a decreased number of Leydig cells and spermatids in the testis, 
absence of the lumen of the seminiferous tubules in the testis, a loss of elongated 
shape the Purkinje cells in the cerebellum and an increase in cell number and 
density in the islets of Langerhans in the pancreas (Figure 10). No histological 
differences between Nephrin/WT/WT and Nephrin/WT/KO mice in observed 
tissues were found. This indicates that one functional nephrin allele is enough to 
produce a relatively normal phenotype. 
 
Figure 10. Histology in JRC-Nephrin x KO mouse tissues. Left panel: Nephrin/WT/WT mouse; 
Right panel: Nephrin/KO/KO mouse. Histological changes found in sites of previously reported 
nephrin expression included: A, B) A decreased number of Leydig cells and spermatids in the 
testis and absence of the lumen of the semiferous tubules. C, D) A loss of elongated shape of the 
Purkinje cells in the cerebellum. E, F) An increase in cell number and density in the islets of 
Langerhans. No difference between Nephrin/WT/WT and Nephrin/WT/KO genotypes was found. 
Magnification: x200. 
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3.3. The nephrin transgene is highly expressed at mRNA and protein level in 
Nephrin/KO/KO mice  
To ensure that progressing ESRD in Nephrin/KO/KO mice is not due to partial 
transgenic rat nephrin expression the following studies were performed. The 
expression of the transgenic rat nephrin mRNA in the kidneys was similar in all 
genotypes at the age of one and six weeks as determined by RT-PCR. The 
expression of endogenous mouse nephrin mRNA was totally absent in 
Nephrin/KO/KO littermate kidneys as expected, while in all other genotypes it was 
indistinguishable (Orig. II, Fig. 4A). 
Immunofluorescence microscopy showed that nephrin was expressed 
similarly in all glomeruli of all genotypes at the age of one week (Orig. II, Fig. 4C). 
Also nephrin protein localization and expression levels remained normal in six-
weeks-old Nephrin/KO/KO mice compared to other genotypes (Orig. II, Fig. 4D). 
This indicates sufficient complementation of the transgenic nephrin protein. 
Surprisingly immunoblotting results show an increased level of the 
phosphorylated nephrin form (~180 kDa) in six-weeks-old Nephrin/KO/KO mice 
compared to other genotypes (Orig. II, Fig. 4B). On SDS-PAGE rat nephrin runs 
as a doublet, presumable because of differential glycosylations, and 
phosphorylated nephrin consistently corresponded to the upper band of size ~180 
kDa [148].  
3.4. Podocyte specific rescue of nephrin alters mRNA and protein 
expression profiles in the kidney 
In order to investigate whether the morphological abnormalities found in the 
kidney, were related to changes in other podocyte-specific mRNA and protein 
expression patterns, other analyses were performed. Many nephrin-associated 
proteins mRNA and protein expression levels were analyzed including podocin, 
synaptopodin, CD2AP, FAT1, Fyn, Nck1 and Nck2. Both subtypes of Nck protein 
were selected for analysis, because of their unknown distribution and role in 
podocytes. 
Results by RT-PCR showed that expression of podocin and Nck2 mRNA 
levels were decreased in six-weeks-old Nephrin/KO/KO mice compared to other 
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genotypes and one-week-old offsprings. Semi-quantification showed a decrease 
in podocin (52 ± 5%) and in Nck2 (43 ± 4%) compared to Nephrin/WT/WT 
controls (Orig. II, Fig. 5). Other significant alterations in mRNA expression levels 
of the measured genes were not found.  
Selected proteins expression and localization was analyzed in the kidney 
cortex using double stainings with synaptopodin. Immunofluorescence stainings 
with podocin, Fyn, Nck1 and Nck2 antibodies in one-week-old mice didn’t reveal 
any appreciated differences in protein expression and localization between the 
genotypes. However, in six-weeks-old Nephrin/KO/KO mice several abnormalities 
in the protein localization were found. Double stainings with synaptopodin showed 
marked decrease in podocin protein in Nephrin/KO/KO mice podocytes compared 
to Nephrin/WT/WT controls. In addition, there was also a decreased in podocin 
mRNA expression level as described earlier. Fyn kinase expression and 
localization was also changed in Nephrin/KO/KO mice. Compared to 
Nephrin/WT/WT mice Fyn protein levels were increased specifically near to the 
podocyte foot processes and SD area. These changes may be related to the 
previously noticed increase in nephrin phosphorylation in six-weeks-old 
Nephrin/KO/KO mice (Orig. II, Fig. 6).  
Also in the Nck family protein subtype characterization differences between 
genotypes were found (Orig. II, Fig. 7). Nck1 was found to be expressed in 
tubules, but some staining was found in the glomeruli as well. However Nck1 did 
not co-localize with synaptopodin and was noticed more in the mesangial parts of 
the glomerulus. No apparent differences between the genotypes were found. 
Instead of Nck1 expression, Nck2 subtype staining was detected to co-localize 
with synaptopodin indicating its expression specifically in podocytes. However 
some tubular expression was also noticed, but it was much less in comparison to 
the Nck1 staining. Interestingly, Nck2 expression in podocytes was totally absent 
in Nephrin/KO/KO mice. Taken together, these findings may indicate that 
Nephrin/KO/KO mice develop a kidney disease before adulthood. This may result 
from the alteration of expression in the proteins that are responsible for nephrin 
tyrosine phosphorylation and intracellular signaling. 
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4. Expression of SD proteins in extra-renal tissues (III) 
4.1. Expression of densin 
In the original publication III, densin expression in the testis and brain were 
evaluated based on previous reports on other podocyte specific molecules. RT-
PCR with densin-specific primers showed mRNA expression in human and mouse 
testicular tissues (Orig. III, Fig. 1). In human brain cortex and in mouse brain 
cortex and cerebellum, densin mRNA expression was detected, this is in 
agreement with previous observations of rat brain tissues [78] and confirms inter-
species close conservation in the brain. These results were verified by 
sequencing the amplified PCR products.  
Positive staining for densin protein was also detected in lysates of human 
and mouse testis by immunoblotting (Orig. III, Fig. 2). The detected size in the 
testis (210 kDa) of densin was similar to that detected in human kidney glomerular 
lysates [79] and in the mouse brain (180 kDa) similar to the originally detected in 
the rat forebrain [78].  
4.2. Localization of densin and other SD components in the testis 
Expression of densin in mouse testis was clearly localized in the cell membranes 
of stained cells (Orig. III, Fig. 3). The localization of densin-positive cells close to 
the basement membrane of the seminiferous tubules suggested them to be 
Sertoli cells. This was confirmed by the distinct Sertoli cell-type nucleus 
appearance of the stained cells as observed with DAPI staining. Identification of 
Sertoli cells with antibody to WT1 [191] in serial testicular sections confirmed that 
the cells stained for densin are indeed Sertoli cells. 
Immunofluorescense staining for β-catenin and cadherins showed that 
these molecules are predominantly localized in the cell membranes of Sertoli cells 
in the mouse testis (Orig. III, Fig. 4). This is consistent with earlier reports on the 
expression of β-catenin and the members of the cadherin family, such as N-
cadherin, in the adherens junctions between Sertoli cells and germ cells [286]. 
Some similarity between the staining patterns of β-catenin and cadherins and 
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densin was detected, but compared to stainings for β-catenin and cadherins, 
densin expression was more tightly restricted to Sertoli cells.  
Double staining experiments using a monoclonal β-catenin antibody 
evaluated potential overlapping antigen distribution of densin and β-catenin. While 
β-catenin was detected in the cell membranes of a number of testicular cell-types, 
double staining with β-catenin and densin showed partial co-localization in cell 
membranes of a particular cell population, most likely Sertoli cells. The specific 
staining pattern suggests an expression of densin in the cell-cell junctions 
between Sertoli cells and germ cells. 
In contrast to the expression patterns of densin, β-catenin and cadherin, 
the expression of ZO-1 was found to be localized in the basal compartment of the 
seminiferous epithelium at the site of the blood-testis barrier. This finding is in 
agreement with earlier detailed studies on ZO-1 expression in rat and mouse 
testis [180]. The staining pattern of densin in comparison with ZO-1 does not 
exclude the possibility of densin being expressed in the blood-testis barrier, 
although densin does not appear to be restricted to the blood-testis barrier. 
5. Long hairpin RNAi construct results in unspecific gene 
silencing in vitro (Unpublished data) 
The purpose of this part of the study was to generate RNAi constructs with a long 
hairpin structure of dsRNA that allows specific, long-term densin and filtrin gene 
silencing in vitro and in vivo. A pDECAP vector was used to clone in the DNA from 
three different fragments of the densin gene and two different fragments of the 
filtrin gene. To test the downregulation efficacy of the RNAi construct, the 
endogenous levels of densin and filtrin mRNA and protein were analyzed in 
mouse insulinoma cells (MIN6) and in mouse kidney cortex collecting duct cells 
(M-1). However the expression levels of both gene’s mRNA and protein were 
below the detection limit as measured by RT-PCR and immunoblotting.  
To measure the silencing in an artificial manner, a modified version of a 
previously reported luciferase-based assay was used [281]. The luciferase-based 
assay was selected because of it’s high sensitivity and the fact that it had been 
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used in the original pDECAP article [281]. The mouse densin or filtrin full-length 
cDNA was cloned into the front of the Renilla luciferase reporter gene of the 
psiCHECK-1 vector. The modified psiCHECK-1 vectors were then co-transfected 
to A293 cells with the RNAi constructs and the control plasmid pGLBasic/SV40P 
with the Firefly luciferase. In the nucleus of the A293 cells, the RNAi constructs 
will be cleaved to siRNA molecules that are targeted against filtrin or densin 
cloned psiCHECK-1 vector. This will silence Renilla luciferase activity that is 
detected with a luminometer.  
 
Table 7: Down-regulation efficiency of RNAi constructs to filtrin and densin mRNA 
levels measured with a luminometer assay.  
 
 
 
 
 
 
 
 
 
Table 7 summarizes the fold changes in RLU by two filtrin constructs and 
three different densin constructs compared to an empty pDECAP control. 
Different transfection ratios of the RNAi construct and the psiCHECK-1 vector at 
different incubation times were tested. The most reliable downregulation efficiency 
was obtained with a 1:1 RNAi/psiCHECK ratio and a 24 h incubation time. Figure 
11 shows the effect of the RNAi constructs to down-regulate the psiCHECK 
reporter vector activity with a mouse filtrin (A) or densin (B) cDNA. These results 
indicate that expression of long filtrin and densin ds-RNA using the pDECAP 
RNAi/ psiCHECK ratio 1:1 1:1 1:2,5 1:5 
Incubation time 24 h 46 h 46 h 46 h 
psiCHECK / Filtrin     
pDECAP 1 1 1 1 
pDECAP / FILT I 0,61 0,6 0,69 0,91 
pDECAP / FILT II 0,62 0,76 - - 
pDECAP / DENS I 0,66 0,49 - - 
pDECAP / DENS II 0,61 1,13 0,96 1,08 
pDECAP / DENS III 0,70 0,88 - - 
     
psiCHECK / Densin     
pDECAP 1 - 1 1 
pDECAP / FILT I 0,71 - 0,65 0,78 
pDECAP / FILT II 0,76 - - - 
pDECAP / DENS I 0,72 - - - 
pDECAP / DENS II 0,60 - 1,34 1,49 
pDECAP / DENS III 0,94 - - - 
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vector degrades significantly at about ~30-40% of the mRNA expression of both 
genes. However no speficity for filtrin or densin was observed (Figure 11). 
  
 
 
 
 
 
 
 
 
Figure 11. The effect of RNAi constructs to down-regulate either the psiCHECK reporter vector 
with a mouse A) filtrin or B) densin cDNA. The RNAi contructs was co-transfected with psiCHECK 
reporter plasmids into A293 cells. After 24 hours, the cells were harvested and the luciferase 
activities measured. The activities produced by the studied constructs were normalized against the 
co-transfected control plasmid (pGLBasic/SV40P) activities. The RLU values represent means ± 
SD of three individual samples. *** The difference to the control with empty expression vector 
(pDECAP) is statistically significant P < 0.001.  
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Discussion 
The aim of this thesis was to provide and test alternative approaches to 
circumvent general problems in conventional gene targeting. Mouse models 
allowing gene manipulation in a specific tissue and cell-type of the adult mouse 
are expected to provide more reliable functional test platforms for diagnostic and 
therapeutics in human diseases compared to the classical ubiquitous gene KO 
mouse-lines. In this thesis, several novel mouse-lines were generated by using 
recent technological advances in the field. All mouse-lines that were developed 
and their proposed future use are summarized in Table 8.  
 
Table 8: Summary mouse-lines generated in this thesis project. 
 
Approach Mouse-line Purpose 
 
Remarks and Future 
Perspectives 
Transgenic JRC-CRE Inducible podocyte-
specific gene deletion. 
Cross-breedings with 
selected floxed-lines. 
Cross-
Breeding 
JRC-CRE x 
Z/AP 
reporter-line 
To test Cre 
recombinase 
functionality. 
Showed podocyte-
specific, doxycycline 
dependent Cre activity.
Transgenic JRC-Nephrin Inducible podocyte-
specific rat nephrin 
over-expression. 
1) Cross-breedings 
with nephrin KO mice. 
2) Disease-induction 
studies.  
Cross-
Breeding 
JRC-Nephrin 
x Nephrin 
KO 
To study if inducible 
transgene expression 
of rat nephrin only in 
podocytes can rescue 
nephrin KO mice from 
perinatal lethality. 
Rescued nephrin KO 
mice, but caused 
severe tissue 
phenotypes need to be 
further characterized. 
RNAi - To down-regulate filtrin 
and densin expression 
in vitro and in vivo. 
Unspecific down-
regulation in vitro. No 
in vivo models. 
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1. General problems in traditional gene targeting  
Even though conventional targeting has provided wide insight into the biological 
functions of many genes, several disadvantages still exist. Conventional KO 
mouse models targeted to podocyte key-molecules lacked time- and tissue-
specific regulation and often cause early postnatal death (See Table 2, Page 48). 
Early disturbance of gene function in ES cells often results in embryonic or 
perinatal lethality. Due to perinatal lethality, conventional KO mouse models of 
genes expressed in the kidney often fail to reveal a detailed biological function of 
these genes in adulthood. Many genes are also expressed in multiple cell types 
and organs, and the resulting KO phenotypes can be complex and difficult to 
study. In addition, early embryonic lethality caused by gene deletion in a specific 
organ can fail to reveal a detailed biological function of the gene within in other 
organs. Therefore, an ideal tool to manipulate gene function would permit tight 
control of expression in a spatial and temporal manner, which is a challenge in 
genetic engineering today. 
Despite some promising results that show regulation of gene deletion in a 
spatial manner using the Cre-loxP system, there are still several aspects that 
need to be considered. Firstly, the degree of Cre-mediated excision during 
embryonic development is critical as incomplete excision might lead to 
unexpected results. Secondly, the exact timing of Cre-mediated excision during 
embryonic development of the tissue or cell of interest is also important and if a 
gene is expressed prior to the time of excision, a less severe phenotype may 
develop. Thirdly, the tissue-specific promoter driving Cre recombinase expression 
may restore cell-specific transcription factors itself, and cause the phenotype. 
Fourthly, Cre expression might be toxic to the mammalian cells [287, 288]. 
Toxicity might be caused by Cre-mediated recombination between endogenous 
sequences that might be targets for Cre [289]. Finally, even with spatial 
expression, embryonic gene deletion by the Cre/lox system often causes a lethal 
phenotype. To avoid this, the Cre/lox system requires not only spatial expression 
but also temporal control of gene expression. 
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2. Novel inducible podocyte-specific mouse-lines (I and II)  
2.1. Novel construct for inducible, cell-specific and single-step gene 
targeting 
The conventional KO or over-expressing mouse models often cause an early 
perinatal death or complicated phenotype, because of the resulting embryonic 
expression of the transgene. In kidney research, there is an increased need for 
cost-effective gene constructs that allows time- and tissue-specific regulation of 
transgene expression in adult mice. A novel approach, based on a single cell-type 
specific doxycycline inducible construct for in vitro studies, and for the generation 
of a transgenic mouse-lines is described in the original publications I and II. 
Several advantages are gained when using a single inducible transgene 
vector that confers site-specific expression after doxycycline induction. First, the 
cell-type specificity can be changed by a single cloning step replacement of one 
cell-specific promoter for another. Second, any gene of interest can be over-
expressed in an inducible and cell-type specific manner by replacing the Cre 
recombinase gene, with the cDNA of the selected gene. Third, the single 
construct gives superior speed and economy in vitro and in vivo, since no multiple 
rounds of cell transfection or oocyte injections and no further breeding steps are 
needed. Fourth, the transgene expression can be turned on or off as desired, 
giving invaluable targeting, e.g. to a particular stage of embryonic development or 
in adult life thus overcoming the limitations of embryonic lethality or redundancy. 
Fifth, oral doxycycline administration is easier to perform in mice compared to the 
intra-peritoneal administration of tamoxifen and it generates less side effects. 
Sixth, doxycycline penetrates the placenta and expression can be triggered during 
embryonic development if necessary.  
Some disadvantages of doxycycline inducible strategies have also been 
reported. A major problem of the Tet-on system is the possible leakiness in un-
induced animals or in other tissues. In the recent improved rtTA versions, such as 
the one used in this study (M2), a far lower tetracycline concentration for the 
induction and thus decreased leakiness occurs [257]. Furthermore, it is 
impossible to estimate the transgene integration-site and the copy-number 
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resulting from the oocyte injection procedure. Additionally, when the cDNA is used 
instead of the genomic sequence, normal post-transcriptional modifications such 
as alternative splicing may not take place due to lack of introns in the sequence. 
2.2. Doxycycline inducible podocyte-specific KO strategy 
Site specific recombinases (e.g. Cre-loxP system) are excellent tools to establish 
tissue-specific gene deletions in the mouse [233]. The cell-type specificity 
depends on the regulation of the tissue-specific promoters that drive the 
expression of the Cre recombinase gene. A drawback of these models is that Cre 
recombinase is expressed during embryonic development and the phenotype 
after gene silencing during embryogenesis, might resemble the phenotype of a 
conventional mouse-line. Thus, both an inducible and a cell-type specific Cre 
recombinase regulation will be needed to silence genes expressed in the adult 
animal.  
The original publication I, describes a transgenic mouse-line with tightly 
regulated inducible expression of Cre recombinase exclusively in the kidney 
podocytes in the adult mouse. This viable and fertile transgenic mouse-line was 
generated by injection of oocytes with a single DNA construct. This construct 
contains a podocin promoter that drives the expression of rtTA and a Cre 
recombinase gene whose expression is initiated by rtTA in the presence of 
doxycycline. Sixteen out of 122 offspring carried the transgene following oocyte 
injection. This is a relatively high integration percent, even though the modified 
construct used was relatively large (~11 kb). All founders were fertile and 
transmitted the transgene to their F1 offspring, enabling further studies and 
breedings. Three founder-lines out of sixteen showed Cre recombinase 
expression in podocytes also without doxycycline administration. Two founder-
lines also showed Cre activity in the heart tissue after two weeks of doxycycline 
administration. This notable leaking only in these founder-lines may be a 
consequence of random integration sites in the genome, number of transgene 
copies integrated to the genome or a “partial” leakiness of the construct in heart 
tissue. For further studies, one founder-line was selected on the basis of its high 
Cre recombinase expression level restricted to podocytes only after doxycycline 
treatment. 
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The successful generation of the novel doxycycline inducible Cre 
recombinase mouse-line will be extremely useful for conditional deletion of 
essential podocyte proteins in the adult mice. This is a unique model for the 
further identification of specific gene functions in physiological and pathological 
conditions in vivo. Furthermore, targeted gene deletion in adult mice provides an 
excellent tool for pharmacologic testing platforms.  
2.3. Doxycycline inducible podocyte-specific over-expression strategy 
Similar to conventional silencing models, over-expression of specific genes during 
embryogenesis might lead to a complicated phenotype, because of failings in the 
exact timing or placing of transgenic expression. The above mentioned single, 
binary Tet-on construct can also be used in over-expressing particular podocyte-
specific proteins in the adult mouse kidney. In the original publication II, a 
transgenic mouse-line with a podocyte specific, doxycycline inducible expression 
of trangenic rat nephrin was generated.  
Following injection of the construct into oocytes 10 out of 90 pups were 
found to carry the transgene, which is a relative high integration percentage. Eight 
out of ten founders transmitted the transgene to their offspring. All founders and 
their F1 offspring were fertile and their phenotypes were normal. Also the rat 
nephrin expression was firmly regulated by the administration of doxycycline and 
observed only in the podocytes. Interestingly, nephrin over-expression in the 
podocytes did not alter the expression or localization of the other studied proteins. 
These results indicate that the inducible construct used is suitable for 
targeted gene over-expression in the adult mouse and in the various tissues by 
changing tissue-specific promoters. This novel doxycycline inducible rat nephrin 
mouse-line will be used to establish, whether nephrin over-expression can protect 
against proteinuria in ligand induced podocyte injury models, including puromycin 
or adriamycin aminonucleocide treatments.  
2.4. Doxycycline inducible podocyte-specific rescue strategy 
In the original publication II, the JRC-Nephrin mouse-line was crossed with a 
nephrin deficient mouse-line [6] to investigate, whether podocyte-specific 
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transgene expression of rat nephrin can rescue nephrin KO mice from perinatal 
lethality. 
Cross-breeding of F1 offspring, which carried transgenic rat nephrin 
expression with heterozygote nephrin KO allele, in the presence of doxycycline 
resulted in the expected number of 14 out of 72 (19%) F2 littermates. Six of these 
pups (five males and one female), which lacked endogenous nephrin but carried 
and expressed the transgenic rat nephrin survived at least six weeks after birth. 
This result shows that nephrin over-expression merely in the podocytes can 
rescue nephrin deficient mice from perinatal death. In addition, this study 
suggests that the lethal phenotype due to nephrin deficiency is mainly caused by 
loss of kidney filtration function. 
All rescued male mice were smaller, infertile and showed impaired 
locomotor activity and genital malformations (See Figure 9, Page 73). Histological 
analysis revealed distinct abnormalities in the kidney, testis, cerebellum and 
pancreas that are reported to express nephrin in WT mice (See Figure 10, Page 
74). This mouse model can be used to study nephrin associated complexes in the 
podocytes after transgenic expression of nephrin originated from other species. 
Most importantly, this mouse-line allows precise characterization of the extra-renal 
tissues after embryonic nephrin loss. 
3. New insights into the role of nephrin in the podocytes by using 
inducible mouse-line (II) 
All rescued Nephrin/KO/KO mice were smaller in body weight and showed severe 
proteinuria at the age of three weeks. Interestingly, females seemed to be more 
sensitive for early death caused by kidney dysfunction and only one survived until 
six weeks of age. The kidneys from six-weeks-old mice were analyzed by light 
microscopy and showed distinct abnormalities including an increase in 
extracellular matrix, focal sclerosis, partly collapsed glomeruli with cystic lesions 
filled with proteinaceous material and dilatations in the tubular profiles. These 
kidney abnormalities were not observed in one-week-old mice and in other 
genotypes, which indicates that morphological changes occurred due to 
endogenous nephrin loss. However, electron microscopy revealed malformations 
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in the podocyte fine structures in Nephrin/KO/KO mice even at both studied ages. 
These mice had distinct foot process effacement but still existing morphologically 
normal SDs. Interestingly, SDs were not found in nephrin deficient newborn pups 
[6]. Although Nephrin/KO/KO mice still had existing SDs, and foot process 
effacement was only partial. The obtained phenotype of these mice resembles the 
findings from podocyte-specific Nck 2 KO in Nck1 null mice [9].  
There are several possible explanations why the podocyte specific 
expression of rat nephrin was not able to restore kidney function completely. 
Perhaps, insufficient rat nephrin expression timing or localization at the protein 
level occurred. At present it is difficult to experimentally determine this, as critical 
cell level protein expression differences are beyond the ability of current methods. 
However, our results showed that transgenic rat nephrin expression level and 
localization appeared similar to endogenous nephrin expression. Nephrin 
antibody staining was also present in all glomeruli in one- and six-weeks-old 
Nephrin/KO/KO mice compared to other genotypes, which suggests sufficient 
complementation in protein expression level.  
Differences between the mouse and rat nephrin gene and protein 
sequence remains a possible reason to explain partial complementation. Rat 
nephrin cDNA was chosen as a transgene because it shares homology with 
mouse nephrin, but has minute differences in the coding sequence, enabling 
distinction from mouse endogenous nephrin by RT-PCR in vivo. However, rat 
nephrin in comparison to mouse nephrin has different tyrosine-based motifs 
(YDEV) in the cytoplasmic tail. This had not been published at the time rat nephrin 
was selected as the transgene. These conserved regions have recently been 
shown to be important for the binding of Nck protein SH2 domain when 
phosphorylated with Src-family kinases, e.g. Fyn [8, 9]. Interestingly, one of these 
two tyrosine motifs that are important in Nck binding in human (1176-YDEV) and 
mouse (1191-YDEV), is not conserved in rat (1187-HDEV) [8, 9, 59]. 
There is an increasing amount of literature of nephrin phosphorylation and 
its role in the maintenance and repair of podocyte foot processes and SD 
(reviewed in Tryggvason et al. 2006). These functions are summarized in Figure 
12. With these findings in mind further evaluations of the significance of different 
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podocyte-specific proteins, which participate in nephrin phosphorylation and 
intracellular signaling in rescued mice, were performed. Indeed, changes in 
podocin, Fyn and Nck2 protein expression and localization in Nephrin/KO/KO 
mice at six weeks of age were found, but not observed in one-week-old 
Nephrin/KO/KO pups. These findings indicated altered intracellular signaling in 
the podocytes after birth. Futhermore, mRNA expression of podocin and Nck2 
was attenuated in six-weeks-old Nephrin/KO/KO mice. These results showed that 
Nck2 protein in the mouse is more prominent in podocytes compared to Nck1 
localization. Interestingly, Nck2 expression in podocytes was totally absent only in 
six-weeks-old Nephrin/KO/KO mice, while expression and localization of these 
proteins were still normal in six-weeks-old littermate controls and one-week-old 
Nephrin/KO/KO mice kidneys. 
These findings indicate that the altered tyrosine residue site in the rat 
nephrin sequence may not be capable of binding to the mouse Nck2 protein and 
thus, mediate its regulatory function to the actin cytoskeleton. Changes in Fyn 
protein expression and localization in six-weeks-old Nephrin/KO/KO mice also 
occurred. This altered Fyn expression may be related to the increase in nephrin 
phosphorylation and may occur in order to compensate for the lack of Nck2 
binding. Nephrin-Nck interaction after Fyn phosphorylation has been shown to be 
important in podocyte foot process development and repair after injury [9, 149]. 
These changes in the expression pattern of key signaling molecules in 
Nephrin/KO/KO mice are associated with the onset and continuous increase of 
proteinuria after three and up to six weeks of age. Interestingly, these findings 
also resembles the phenotype in mice with podocyte-specific Nck deficiency [9].  
In conclusion the extracellular domain of rat nephrin protein appears to be 
efficient in forming the functional SD structure in the rescued nephrin deficient 
mice, as shown by electron microscopy. Furthermore, these results indicate that 
nephrin may have a bigenic role in the podocytes, both in the formation of 
functional filtration slit during development and also in maintaining foot process 
integrity during adulthood, via Nck2 signaling. However, this remains to be 
elucidated in greater detail. 
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Figure 12. Nephrin phosphorylation and its role in the maintenance and repair of podocyte foot 
processes and SD. Prior to formation of the foot processes and the slit diaphragm, prepodocytes 
covering the glomerular capillaries are connected by tight junctions. During formation of the foot 
processes, nephrin (N) becomes phosphorylated (P), possibly upon encountering its extracellular 
ligand, which results in recruitment of Nck adaptor proteins and induction of actin polymerization. 
Once the slit diaphragm is assembled, the nephrin molecules are dephosphorylated and nephrin is 
connected to actin through CD2AP, podocin (Pc), and possibly some other proteins. Following 
injury of the slit diaphragm leading to foot-process effacement and proteinuria, nephrin molecules 
become clustered, which induces their phosphorylation, Nck association, and actin polymerization. 
Finally, upon injury repair, the nephrin molecules are dephosphorylated and the slit diaphragm-
actin filament complex is restored to the normal mature foot processes. This figure is reprinted 
with permission from reference 146.  
 
4. SD components role in extra-renal tissues (II and III) 
4.1. Testis 
4.1.1. Nephrin deficiency causes abnormalities in testis development 
In the original publication II, all rescued nephrin deficient male mice were infertile 
and compared to WT littermates their genitals showed gross anatomical 
malformations; penises were smaller, testicles had not descended, seminal 
vesicle formation was severely impaired, a decreased number of Leydig cells and 
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a few morphologically normal spermatids in the testis were observed (See Figures 
9 and 10, Pages 73 and 74). Remarkably, these findings show strong similarities 
to the data of the in vivo complementation experiments with another protein 
crucial for podocyte function, CD2AP [117]. Podocyte-specific expression of 
CD2AP cDNA, allowed rescuing of CD2AP KO mice from post-natal lethality by 
restoring renal function. This also uncovered a hidden phenotype characterized 
by infertility and testicular abnormalities [117].  
Interestingly structural changes were observed in six-weeks-old 
Nephrin/KO/KO mouse testicles in structures, which have been shown to originate 
from the mesonephros during the genitoureteric development. These changes 
include incorrect structure of seminiferous cords [168, 169] and absence of Leydig 
cells [172]. During development, extensive cell migration between the 
mesonephros and the developing testis occurs [167]. Furthermore, the expression 
of nephrin protein and its regulatory protein WT1, have been shown to be 
detectable for the first time during the mesonephros stage of development [4, 5, 
59, 61, 176]. Recently, the role of another Ig-family protein, filtrin has been shown 
to be involved in the migration of early postmitotic neural precursors during mouse 
CNS development [206]. Based on the results of this study, nephrin protein may 
have a role during the organogenesis of testis and mesonephric cell migration. 
However these speculations will need further verification.    
Currently treatment with early nephrectomy and subsequent dialysis 
followed by renal transplantation is used to treat CNF patients lacking nephrin in 
their kidneys [44]. This treatment perhaps together with the immune suppressants 
act to prevent rejection of the transplanted kidney, and this treatment appears to 
remove all symptoms with no confirmed later manifestations in other organs [45]. 
Interestingly, two male CNF patients showed decreased serum levels of inhibin B 
[65] thus suggesting arrested spermatogenesis [290]. The first successfully 
treated CNF patients are only now entering their reproductive years. Thus, it is 
still premature to speculate on possible consequences of nephrin deficiency for 
fertility in humans.  
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4.1.2. Densin is also expressed in the testis 
The original publication III, reports densin as a novel testicular protein in addition 
to its expression in the kidney and brain [78, 79]. Firstly RT-PCR analysis showed 
the presence of densin mRNA in human and mouse testis. Secondly, western 
blotting confirmed the expression of the densin protein (approx. 210 kDa) in the 
testis, this same size has also been reported in the kidney [79]. Thirdly, 
immunofluorescence staining revealed that the densin protein is specifically 
localized to the cell membranes of Sertoli cells. In consideration to the 
known/anticipated function of densin in the brain and the kidney it is suggested 
here, that densin may function as an adherens junction protein between the 
Sertoli cell and the developing germ cells.  
Densin expression was specifically confined to the cell membranes of 
Sertoli cells, with an expression pattern resembling that of cadherins and β-
catenin. Members of the catenin and cadherin families are ubiquitously expressed 
proteins which form structural and signaling complexes in numerous organs. In 
the testis, there is accumulating knowledge of the important functional role of the 
catenin/cadherin complexes particularly in the adherens junctions between Sertoli 
cells and germ cells, and thus play a role in spermatogenesis [193, 286, 291, 
292].These findings may indicate a potential structural/functional interaction of 
densin with the catenin/cadherin complex in Sertoli cells. In the brain, densin 
associates with N-cadherin via neural specific catenin, δ-catenin/neural 
plakophilin-related armadillo repeat protein [88]. Furthermore recent data from the 
kidney, show that there is an interaction between densin and ß-catenin in the 
podocytes [91]. Therefore, it is hypothesized that densin may also interact with 
the catenin/cadherin complexes in the adherens junctions of the testis, however 
this needs further study. The testis as an extracorporeal paired organ may 
become an important and feasible site to test the functional relevance of the 
nephrin complex of proteins. 
4.1.3. Hypothetical role of densin in the testis 
As stated above, the functional role of densin as a part of nephrin complex of 
proteins in the testis remains to be clarified. In the brain, there is evidence that 
densin is involved in establishing cell polarity, assembling signaling complexes in 
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the postsynaptic membranes at the glutamatergic synapses and in establishment 
of cell-cell contacts [88, 89]. The role of densin also in the kidney remains to be 
fully characterized, but preliminary results suggest that densin interacts with 
several components of the podocyte filtration SD either directly or indirectly and 
thus is associated with the assembly of SD protein complexes. Collectively, the 
previous knowledge of the role and functions of densin in non-testicular tissues 
suggests that densin is an adhesion molecule, important in establishing cell-cell 
contacts and controlling signaling between Sertoli cells and developing germ 
cells. 
The precise generic functions of junction complexes apparently shared in 
various tissues remains to be clarified. Meanwhile testis may present itself as one 
of the most easily accessible tissues, to gain information on the structure and the 
precise functions of these complexes, as has been suggested earlier [293]. 
Consequently, advances in the understanding of functions in one tissue may offer 
valuable clues to understanding other tissues, especially those which share 
structural similarities. 
Spermatogenesis in the seminiferous epithelium of the mammalian testis is 
a dynamic cellular event, in which Sertoli-germ cell actin-based adherens 
junctions appear to be involved. The restructuring at the Sertoli-germ cell 
interface, permits germ cells to traverse the epithelium from basal to adluminal 
compartment [193]. The current knowledge of the regulation of adherens junction 
dynamics by interactions between adherens junction integral membrane proteins, 
phosphatases, kinases, adaptors, and the underlying cytoskeleton network has 
previously been described [193].  
Interference of Sertoli-germ cell interactions in the testis, has been shown 
to affect germ cell movement within the epithelium [193, 291, 294]. Therefore 
manipulation of Sertoli-germ cell adherens junctions has been identified as a 
potential target for a male contraceptive pill. This has led to calls to identify and 
characterize novel proteins at the various junction types in the testis [294]. 
Interestingly it has recently been shown (with an intratesticular androgen 
suppression-induced germ cell loss model) that disruption of adherens junctions, 
can be limited to the Sertoli-germ cell interface without perturbing the blood-testis 
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barrier [295]. The identification of densin in the present study has increased our 
knowledge of the molecular composition of the testicular junctions. Identification 
of the exact junction types that densin is involved with, as well as deciphering the 
exact assembly of the densin-linked junctions is warranted. Further work on the 
functional role of densin is also needed to reveal whether densin has a role in 
spermatogenesis and as a target for male contraceptives.  
4.2. CNS 
In the original article II, rescued nephrin deficient mice showed a disarray of the 
Purkinje cells in the cerebellum (See Figure 10, Page 74). The data from the 
primary behavioral screening of the rescued mice indicate severe motor defects 
(See Table 5, Page 71). Interestingly neurological symptoms are frequently found 
in the nephrectomized, transplanted and treated CNF patients [66]. These 
findings suggest a role for nephrin in regulating locomotor activity in mice, while 
more detailed characterization at a cellular and molecular level will be needed to 
substantiate this hypothesis in humans. 
4.3. Pancreas 
In the original article II, rescued nephrin deficient mice also showed a strong 
increase in the number of Islets of Langerhans in the pancreas and decreased 
glucose levels in the blood (See Figure 10 and Table 6, Pages 74 and 72). The 
blood glucose levels were relatively high in Nephrin/WT/WT (13.2 mmol/l) and 
Nephrin/WT/KO (10.3 mmol/l) mice compared to normal glucose levels in mice. 
However, the blood glucose levels measured in one-week-old Nephrin/WT/WT 
(5.8 mmol/l) and Nephrin/WT/KO (6.3 mmol/l) pups were normal (Data not 
shown). This finding indicates that elevated blood glucose levels in six-weeks-old 
controls may be due to the administration of 5% sucrose to the drinking water 
after birth.  These findings may also indicate changes in pancreas function 
because of pancreatic nephrin loss during embryogenesis, and the resulting 
changes in glucose homeostasis. However, an increased incidence of diabetes 
has not been observed in treated CNF patients (C Holmberg, personal 
communication). It is speculated that life long treatment with immunosuppressants 
to prevent rejection of the transplanted kidney protects these patients against the 
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development of type I diabetes. However, these results are still very preliminary 
and will need further investigation. 
5. Long hairpin RNAi construct pDECAP fails to provide a tool for 
gene downregulation in vivo (Unpublished data)  
Although conventional and conditional KO mouse-lines are useful for analyzing 
gene function, their generation in ES cells is very expensive and time-consuming. 
A rough estimation of time required spans between 12-24 months and costs about 
50000-100000 euros. Chemically synthesized siRNA [277, 278] or plasmid based 
RNAi [276] provides an alternative approach by inducing sequence-specific 
mRNA degradation. Both approaches have been used successfully in gene 
silencing in podocyte cell-cultures [103, 112, 296, 297]. Very recently, nephrin 
was silenced with synthesized siRNA in WT podocytes [297]. Nephrin down-
regulation abrogated the insulin response, and stable nephrin transfection of 
nephrin-deficient podocytes rescued their insulin response. This work 
demonstrated a previously unsuspected role for nephrin in vesicular docking and 
insulin responsiveness of podocytes [297]. In an other recent study, RNAi 
expression vector (pSilencer 2.1-U6) specifically targeted against podocin mRNA 
was transfected into the mouse podocyte clone (MPC5), and the molecular 
interactions among podocin, nephrin, and alpha-actinin-4 were studied [103]. This 
study showed that the silencing of podocin also decreased nephrin expression, 
whereas the expression and distribution of alpha-actinin-4 showed no change. 
These results suggested that podocin may interact directly with nephrin, but not 
with alpha-actinin [103]. Together these results show that the RNAi method is 
feasible when cultured cells for example podocytes are used. 
Although the RNAi approach has been used successfully in podocyte cell-
lines, no results of downregulation in podocytes in vivo have been published. The 
main problem with synthesized siRNA in vivo, is that it produces only transient 
mRNA degradation. The major difficulty in the use of long dsRNA transcribed from 
the Pol II or Pol III promoter in vivo is that this procedure induces the interferon 
response. In mammals, the dsRNA transcripts longer than 30 nucleotides are 
immediately transferred from the nucleus to the cytosol, where they induce 
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interferon synthesis leading to a block in translation and nonspecific mRNA 
degradation [278]. To prevent the interferon response, we used the pDECAP 
vector in our approach. The pDECAP transcript lacks both the 5´-cap structure 
and the 3´-pA tail and the lack of these structures prevents the export of dsRNA to 
the cytosol and prevents the interferon response [281]. The ribonuclease(s) such 
as Dicer which cleave long ds-RNA are localized both in the nucleus and the 
cytoplasm [283], and the long ds-RNA expressed by this vector is thought to be 
processed into siRNA already within the nucleus. The processed siRNA moves to 
the cytosol and causes the degradation of the target mRNA only [273].  
The results in vitro showed that the expression of long filtrin and densin ds-
RNA using the pDECAP vector leads to degradation of ~30-40% of the mRNA 
levels of both genes (See Table 7 and Figure 11, Pages 79 and 80). However, 
this downregulation was not target specific. This may be due to; 1) a still existing 
interferon response because of too long fragments of processed siRNA (more 
than 30 nucleotides); 2) the dsRNA fragments used are too long (500 bp) and 
results in too many siRNA molecules; 3) a homology between filtrin and densin 
mRNA sequences. 
However, due to the high cost of the generation and maintenance of 
mouse-lines by the microinjection procedure or lentiviral transfection, the 
efficiency of these constructs to downregulate filtrin and densin expression in vivo 
was not examined further. Moreover, a report from another academic group 
stated that, they didn’t either achieve selective gene silencing in vivo using the 
pDECAP vector (H Lohi, personal communication). As a conlusion, there is still a 
need to resolve some of the remaining practical problems in use of the pDECAP 
and other RNAi systems in vivo in the future. 
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Future perspectives 
These novel mouse-lines provide an excellent tool for conditional, kidney 
glomerular podocyte specific gene deletion and over-expression in adult mice. 
Rescuing of nephrin deficient mice from perinatal death has enabled us for the 
first time, to study consequences of nephrin deficiency in extra-renal tissues in 
adulthood. Further studies to characterize detailed consequences of nephrin 
deficiency in the extra-renal tissues at a cellular and molecular level have already 
been started. 
In the kidney research field it is an absolute necessity to study the 
regulation of gene expression in the adult animal. The availability of different 
floxed lines of distinct gene sets will allow podocyte-specific deletions by cross-
breedings with the Cre-line. The floxed nephrin mouse-line has already been 
generated with Professor Josef Verbeek, Department of Genetics, University of 
Leiden. These novel mice will shed more light into the role of nephrin deficiency in 
the adult kidney and in other tissues. 
These mouse-lines and the results obtained from them, will lead to a 
deeper understanding of the disease mechanisms in the kidney glomeruli. New 
understanding is urgently needed because of the enormously increasing 
prevalence of chronic kidney diseases, particularly diabetic kidney damage, which 
invariably starts with podocyte failure. Dysregulation of SD components, 
especially nephrin, is emerging as an important mechanism leading to loss of the 
filtration barrier function in diabetic nephropathy.  
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